STOCK TITAN

Auddia's nine-month loss widens to $7.37M in 2026

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Auddia Inc. (AUUD) reported $22,268 in revenue for the nine months ended September 30, 2026, versus $0 a year earlier; the company attributed the revenue to Discovr Radio subscriptions. Net loss rose to $7,370,076 from $5,702,369. In the third quarter, revenue was $14,684 and net loss narrowed to $2,113,257 from $2,381,151. Operating cash use was $6,916,748 for the nine months, versus $4,335,812 a year earlier.

Cash and cash equivalents were $6,024,316 at September 30, 2026. Auddia said it secured approximately $12.9 million in 2026 financing through the report date, enough to fund current operating plans into the second quarter of 2027, but additional funding is needed; recurring losses and financing needs raise substantial doubt about its ability to continue as a going concern. The proposed merger with Thramann Holdings is expected to close in the first quarter of 2027, subject to stockholder approval, effectiveness of an S-4 registration statement to be filed, continued Nasdaq listing and at least $12 million cash on hand at closing.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Minor pointThird-quarter net loss narrowed 11.3% to $2,113,257.

Negative

  • Major pointNine-month net loss increased 29.2% to $7,370,076.
  • Major point. Forward-looking: it has not happened yet and may not happen.Management cited substantial doubt about continued operations; current plans are funded into Q2 2027.

Filing Explained

Auddia has exchanged 580,023 warrants for 1,160,045 newly issued shares; another 4,135,539 warrants would be exchanged for 8,271,077 shares only with stockholder approval and remain outstanding until then, so the issued shares reduce existing holders’ ownership percentages, with further dilution dependent on approval.

Revenue $22,268 Nine months ended September 30, 2026; $0 in the comparable 2025 period.
Net loss -$7,370,076 Nine months ended September 30, 2026; -$5,702,369 in the comparable 2025 period.
Net cash used in operating activities -$6,916,748 Nine months ended September 30, 2026; -$4,335,812 in the comparable 2025 period.
Cash and cash equivalents $6,024,316 As of September 30, 2026.
Additional financing secured Approximately $12.9 million During 2026 through the report date.
Operating-plan funding horizon Into the second quarter of 2027 Management said the financing secured would fund current operating plans through this period.
Merger cash condition At least $12 million Cash on hand required at closing of the proposed merger.
Discovr Radio plays More than 550,000 plays Total plays across customers since the platform's release.
going concern financial
"substantial doubt as to the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
at-the-market offering financial
"through an at the market offering"
An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.
Pre-Funded Warrants financial
"all 3,679,737 Pre-Funded Warrants were exercised"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
ASC 815-40 technical
"under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity"
performance obligation financial
"recognizes revenue when it satisfies a performance obligation"
A performance obligation is a specific promise in a contract to deliver a good or provide a service to a customer, and it is the unit companies use to decide when and how much revenue to record. Think of it like checklist items in a service agreement: each item completed can trigger part of the payment to be recognized as revenue. Investors care because how obligations are identified and satisfied changes the timing and amount of reported revenue and profits, affecting comparisons and valuation.
working capital financial
"working capital of approximately $5,601,721 as of September 30, 2026"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue and net loss did AUUD report for the first nine months of 2026?

Auddia reported $22,268 in revenue and a $7,370,076 net loss for the nine months ended September 30, 2026. Revenue was $0 and net loss was $5,702,369 in the comparable 2025 period.

How long does AUUD expect its 2026 financing to fund operations?

Auddia said approximately $12.9 million in financing secured during 2026 through the report date will fund its current operating plans into the second quarter of 2027. The company also said additional funding is needed to complete development of its full product line and scale products with demonstrated market fit.

What conditions apply to AUUD's proposed merger with Thramann Holdings?

The merger is expected to close in the first quarter of 2027, subject to Auddia stockholder approval, effectiveness of an S-4 registration statement to be filed, continued Nasdaq listing and at least $12 million cash on hand at closing.

How many plays has AUUD's Discovr Radio delivered?

Since its release, Discovr Radio has delivered more than 550,000 total plays across all customers. Participating artists were seeing an average of 100 radio plays per week.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 2026 Q3 --12-31 0001554818 1 1 0001554818 2026-01-01 2026-09-30 0001554818 2026-11-12 0001554818 2026-09-30 0001554818 2025-12-31 0001554818 us-gaap:SeriesCPreferredStockMember 2026-09-30 0001554818 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001554818 2026-07-01 2026-09-30 0001554818 2025-07-01 2025-09-30 0001554818 2025-01-01 2025-09-30 0001554818 AUUD:PreferredStockSeriesBMember 2025-12-31 0001554818 AUUD:PreferredStockSeriesCMember 2025-12-31 0001554818 us-gaap:CommonStockMember 2025-12-31 0001554818 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001554818 us-gaap:RetainedEarningsMember 2025-12-31 0001554818 AUUD:PreferredStockSeriesBMember 2026-03-31 0001554818 AUUD:PreferredStockSeriesCMember 2026-03-31 0001554818 us-gaap:CommonStockMember 2026-03-31 0001554818 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001554818 us-gaap:RetainedEarningsMember 2026-03-31 0001554818 2026-03-31 0001554818 AUUD:PreferredStockSeriesBMember 2026-06-30 0001554818 AUUD:PreferredStockSeriesCMember 2026-06-30 0001554818 us-gaap:CommonStockMember 2026-06-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001554818 us-gaap:RetainedEarningsMember 2026-06-30 0001554818 2026-06-30 0001554818 AUUD:PreferredStockSeriesBMember 2024-12-31 0001554818 AUUD:PreferredStockSeriesCMember 2024-12-31 0001554818 us-gaap:CommonStockMember 2024-12-31 0001554818 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001554818 us-gaap:RetainedEarningsMember 2024-12-31 0001554818 2024-12-31 0001554818 AUUD:PreferredStockSeriesBMember 2025-03-31 0001554818 AUUD:PreferredStockSeriesCMember 2025-03-31 0001554818 us-gaap:CommonStockMember 2025-03-31 0001554818 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001554818 us-gaap:RetainedEarningsMember 2025-03-31 0001554818 2025-03-31 0001554818 AUUD:PreferredStockSeriesBMember 2025-06-30 0001554818 AUUD:PreferredStockSeriesCMember 2025-06-30 0001554818 us-gaap:CommonStockMember 2025-06-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001554818 us-gaap:RetainedEarningsMember 2025-06-30 0001554818 2025-06-30 0001554818 AUUD:PreferredStockSeriesBMember 2026-01-01 2026-03-31 0001554818 AUUD:PreferredStockSeriesCMember 2026-01-01 2026-03-31 0001554818 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001554818 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001554818 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001554818 2026-01-01 2026-03-31 0001554818 AUUD:PreferredStockSeriesBMember 2026-04-01 2026-06-30 0001554818 AUUD:PreferredStockSeriesCMember 2026-04-01 2026-06-30 0001554818 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001554818 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001554818 2026-04-01 2026-06-30 0001554818 AUUD:PreferredStockSeriesBMember 2026-07-01 2026-09-30 0001554818 AUUD:PreferredStockSeriesCMember 2026-07-01 2026-09-30 0001554818 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001554818 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001554818 AUUD:PreferredStockSeriesBMember 2025-01-01 2025-03-31 0001554818 AUUD:PreferredStockSeriesCMember 2025-01-01 2025-03-31 0001554818 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001554818 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001554818 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001554818 2025-01-01 2025-03-31 0001554818 AUUD:PreferredStockSeriesBMember 2025-04-01 2025-06-30 0001554818 AUUD:PreferredStockSeriesCMember 2025-04-01 2025-06-30 0001554818 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001554818 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001554818 2025-04-01 2025-06-30 0001554818 AUUD:PreferredStockSeriesBMember 2025-07-01 2025-09-30 0001554818 AUUD:PreferredStockSeriesCMember 2025-07-01 2025-09-30 0001554818 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001554818 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001554818 AUUD:PreferredStockSeriesBMember 2026-09-30 0001554818 AUUD:PreferredStockSeriesCMember 2026-09-30 0001554818 us-gaap:CommonStockMember 2026-09-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001554818 us-gaap:RetainedEarningsMember 2026-09-30 0001554818 AUUD:PreferredStockSeriesBMember 2025-09-30 0001554818 AUUD:PreferredStockSeriesCMember 2025-09-30 0001554818 us-gaap:CommonStockMember 2025-09-30 0001554818 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001554818 us-gaap:RetainedEarningsMember 2025-09-30 0001554818 2025-09-30 0001554818 2025-03-27 2025-03-28 0001554818 2026-03-27 2026-03-31 0001554818 2025-01-01 2025-12-31 0001554818 AUUD:DomainNameMember 2026-09-30 0001554818 AUUD:DomainNameMember 2025-12-31 0001554818 us-gaap:PatentsMember 2026-09-30 0001554818 us-gaap:PatentsMember 2025-12-31 0001554818 AUUD:ThramannHoldingsMember us-gaap:BridgeLoanMember 2026-07-17 0001554818 AUUD:LT350Member us-gaap:BridgeLoanMember 2026-07-17 0001554818 AUUD:InfluenceHealthCareMember us-gaap:BridgeLoanMember 2026-07-17 0001554818 AUUD:VoyexMember us-gaap:BridgeLoanMember 2026-07-17 0001554818 us-gaap:BridgeLoanMember 2026-09-30 0001554818 us-gaap:BridgeLoanMember 2026-07-17 0001554818 us-gaap:AccountsPayableMember 2026-09-30 0001554818 us-gaap:AccountsPayableMember 2025-12-31 0001554818 us-gaap:AccruedLiabilitiesMember 2026-09-30 0001554818 us-gaap:AccruedLiabilitiesMember 2025-12-31 0001554818 AUUD:CreditCardsPayableMember 2026-09-30 0001554818 AUUD:CreditCardsPayableMember 2025-12-31 0001554818 AUUD:DAndOInsurancePremiumMember 2025-06-20 0001554818 AUUD:DAndOInsurancePremiumMember 2025-06-19 2025-06-20 0001554818 AUUD:DAndOInsurancePremiumMember 2026-09-30 0001554818 AUUD:DAndOInsurancePremiumMember 2025-12-31 0001554818 us-gaap:StockOptionMember 2025-12-31 0001554818 us-gaap:StockOptionMember 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember 2026-09-30 0001554818 us-gaap:StockOptionMember 2024-12-31 0001554818 us-gaap:StockOptionMember 2025-01-01 2025-09-30 0001554818 us-gaap:StockOptionMember 2025-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice1Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice1Member 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice2Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice2Member 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice3Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice3Member 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice4Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice4Member 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice5Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice5Member 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice6Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice6Member 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice7Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice7Member 2026-01-01 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice8Member 2026-09-30 0001554818 us-gaap:StockOptionMember AUUD:ExercisePrice8Member 2026-01-01 2026-09-30 0001554818 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0001554818 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-09-30 0001554818 us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001554818 AUUD:StockOptionsAndRestrictedStockUnitsRSUMember 2026-07-01 2026-09-30 0001554818 AUUD:StockOptionsAndRestrictedStockUnitsRSUMember 2025-07-01 2025-09-30 0001554818 AUUD:StockOptionsAndRestrictedStockUnitsRSUMember 2026-01-01 2026-09-30 0001554818 AUUD:StockOptionsAndRestrictedStockUnitsRSUMember 2025-01-01 2025-09-30 0001554818 AUUD:EquityLineCommonStockPurchaseAgreementMember 2024-11-25 0001554818 AUUD:EquityLineCommonStockPurchaseAgreementMember 2025-07-30 0001554818 AUUD:EquityLineCommonStockPurchaseAgreementMember 2025-01-01 2025-12-31 0001554818 AUUD:ATMOfferingMember 2026-01-01 2026-09-30 0001554818 AUUD:ATMOfferingMember 2026-07-01 2026-09-30 0001554818 AUUD:ATMOfferingMember 2025-01-01 2025-12-31 0001554818 AUUD:April2024SPAMember 2024-04-22 2024-04-23 0001554818 AUUD:April2024SPAMember us-gaap:SeriesBPreferredStockMember 2024-04-22 2024-04-23 0001554818 AUUD:April2024SPAMember us-gaap:SeriesBPreferredStockMember 2024-04-23 0001554818 AUUD:April2024SPAMember us-gaap:SeriesBPreferredStockMember 2024-04-24 0001554818 AUUD:April2024SPAMember us-gaap:SeriesBPreferredStockMember 2025-02-18 2025-02-19 0001554818 AUUD:April2024SPAMember us-gaap:CommonStockMember 2025-02-18 2025-02-19 0001554818 AUUD:April2024SPAMember us-gaap:SeriesBPreferredStockMember 2025-04-01 2025-04-30 0001554818 AUUD:April2024SPAMember us-gaap:CommonStockMember 2025-04-01 2025-04-30 0001554818 AUUD:April2024SPAMember us-gaap:SeriesBPreferredStockMember 2025-06-25 2025-06-26 0001554818 AUUD:April2024SPAMember us-gaap:CommonStockMember 2025-06-25 2025-06-26 0001554818 AUUD:ExchangeAgreementsMember us-gaap:SeriesBPreferredStockMember 2025-08-04 2025-08-05 0001554818 AUUD:ExchangeAgreementsMember us-gaap:CommonStockMember 2025-08-04 2025-08-05 0001554818 us-gaap:SeriesBPreferredStockMember 2026-09-30 0001554818 AUUD:June2025SPAMember 2025-06-29 2025-06-30 0001554818 AUUD:June2025SPAMember us-gaap:SeriesCPreferredStockMember 2025-06-29 2025-06-30 0001554818 AUUD:June2025SPAMember us-gaap:SeriesCPreferredStockMember 2026-04-01 2026-04-23 0001554818 AUUD:June2025SPAMember us-gaap:CommonStockMember 2026-04-01 2026-04-23 0001554818 AUUD:RegisteredDirectOfferingMember 2026-04-26 2026-04-27 0001554818 AUUD:PreFundedWarrantsMember AUUD:RegisteredDirectOfferingMember 2026-04-27 0001554818 AUUD:CommonWarrantsMember AUUD:RegisteredDirectOfferingMember 2026-04-27 0001554818 AUUD:RegisteredDirectOfferingMember 2026-04-27 0001554818 AUUD:RegisteredDirectOfferingMember AUUD:CommonWarrantsMember 2026-09-30 0001554818 AUUD:RegisteredDirectOfferingMember AUUD:CommonWarrantsMember 2026-01-01 2026-09-30 0001554818 AUUD:RegisteredDirectOfferingMember AUUD:PreFundedWarrantsMember 2026-09-30 0001554818 AUUD:SeriesCPreferredStockIssuanceMember 2026-01-01 2026-09-30 0001554818 AUUD:SeriesCPreferredStockIssuanceMember 2025-01-01 2025-12-31 0001554818 us-gaap:BlackScholesMertonModelMember 2026-01-01 2026-09-30 0001554818 us-gaap:WarrantMember 2025-12-31 0001554818 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001554818 us-gaap:WarrantMember 2026-09-30 0001554818 us-gaap:WarrantMember 2024-12-31 0001554818 us-gaap:WarrantMember 2025-01-01 2025-09-30 0001554818 us-gaap:WarrantMember 2025-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure AUUD:Integer

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ Quarterly REPORT pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
For the quarterly period ended September 30, 2026
 
Or
 
☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
For the transition period from _____________ to _____________

 

Commission File No. 001-40071

 

AUDDIA INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   45-4257218
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     

1680 38th Street, Suite 130

Boulder, CO

  80301
Address of Principal Executive Offices   Zip Code

 

(303) 219-9771

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   AUUD   The Nasdaq Stock Market

 

Indicate by check mark whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐ Accelerated Filer ☐
Non-accelerated Filer ☒ Smaller Reporting Company ☒
  Emerging Growth Company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b)-2 of the Exchange Act). Yes ☐  No ☒

 

As of November 12, 2026, there were 6,913,620 shares of the registrant’s common stock, $0.001 par value per share, outstanding.

 

 

   

AUDDIA INC.

2026 QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

 

    Page No.
     
PART I – FINANCIAL INFORMATION
     
Item 1. Financial Statements 4
  Condensed Balance Sheets (Unaudited) 4
  Condensed Statements of Operations (Unaudited) 5
  Condensed Statements of Changes in Shareholders’ Equity (Unaudited) 6
  Condensed Statements of Cash Flows (Unaudited) 8
  Notes to Condensed Financial Statements (Unaudited) 9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
Item 3. Quantitative and Qualitative Disclosures About Market Risk 37
Item 4. Controls and Procedures 38
     
PART II – OTHER INFORMATION
     
Item 1. Legal Proceedings 39
Item 1A. Risk Factors 39
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39
Item 3. Defaults Upon Senior Securities 39
Item 4. Mine Safety Disclosures 39
Item 5. Other Information 39
Item 6. Exhibits 40
  Signatures 42

 

 

Unless we state otherwise or the context otherwise requires, the terms “Auddia,” “we,” “us,” “our” and the “Company” refer to Auddia Inc., a Delaware corporation.

 

 

 

 2 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q, or Quarterly Report, contains forward-looking statements that involve risks and uncertainties. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this Quarterly Report are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expects”, “intends”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, “continue” or the negative of these terms or other comparable terminology.

 

Forward-looking statements are neither historical facts nor assurances of future performance, and are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

 

· risks related to the proposed merger with Thramann Holdings;
· the sufficiency of our existing cash to meet our working capital and capital expenditure needs over the next 12 months and our need to raise additional capital;
· our ability to generate revenue from new software services;
· our limited operating history;
· our ability to maintain proper and effective internal financial controls;
· our ability to continue to operate as a going concern;
· changes in laws, government regulations and policies and interpretations thereof;
· our ability to obtain and maintain protection for our intellectual property;
· the risk of errors, failures or bugs in our platform or products;
· our ability to attract and retain qualified employees and key personnel;
· our ability to manage our rapid growth and organizational change effectively;
· the possibility of security vulnerabilities, cyberattacks and network disruptions, including breaches of data security and privacy leaks, data loss, and business interruptions;
· our compliance with data privacy laws and regulations;
· our ability to develop and maintain our brand cost-effectively;
· our ability to complete the proposed business combination;
· our ability to maintain the listing of our common stock on the Nasdaq Stock Market; and
· the other factors set forth elsewhere in this Quarterly Report and in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2025.

 

These forward-looking statements speak only as of the date of this Form 10-Q and are subject to business and economic risks. We do not undertake any obligation to update or revise the forward-looking statements to reflect events that occur or circumstances that exist after the date on which such statements were made, except to the extent required by law.

 

 

 3 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Auddia Inc.

Condensed Balance Sheets

           
   September 30, 2026   December 31, 2025 
   (Unaudited)     
ASSETS          
Current assets:          
Cash and cash equivalents  $6,024,316   $3,186,985 
Accounts receivable, net   564    321 
Prepaid assets   67,506    99,829 
Other current assets   25,913    10,039 
Total current assets   6,118,299    3,297,174 
           
Non-current assets:          
Notes receivable-Related party   1,175,269    – 
Property and equipment, net of accumulated depreciation   4,082    6,670 
Intangible assets, net of accumulated amortization   33,265    25,785 
Software development costs, net of accumulated amortization   1,633,161    1,608,819 
Operating lease right of use asset   20,184    44,392 
Deferred offering costs   123,772    219,615 
Total non-current assets   2,989,733    1,905,281 
Total assets  $9,108,032   $5,202,455 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable and accrued liabilities  $488,400   $853,354 
Deferred Revenue   3,115    – 
Notes payable   –    60,520 
Current portion of operating lease liability   25,063    38,612 
Total current liabilities   516,578    952,486 
Non-current operating lease liability   –    14,475 
Total liabilities   516,578    966,961 
           
Commitments and contingencies (Note 6)        – 
           
Shareholders’ equity:          
Series C Preferred stock - $0.001 par value, 0 and 750 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively   –    1 

Common stock - $0.001 par value, 100,000,000 authorized and 5,803,182 issued and outstanding as of September 30, 2026 and 402,833 issued and outstanding as of December 31, 2025, respectively

   5,803    403 
Additional paid-in capital   113,269,393    101,518,433 
Accumulated deficit   (104,683,742)   (97,283,343)
Total shareholders’ equity   8,591,454    4,235,494 
Total liabilities and shareholders’ equity  $9,108,032   $5,202,455 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

(1) The Company’s common stock outstanding as of September 30, 2026 and December 31, 2025 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026.

 

 

 

 4 

 

Auddia Inc.

Condensed Statements of Operations

(Unaudited)

                     
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Revenue  $14,684   $–   $22,268   $– 
                     
Operating expenses:                    
Direct cost of services   104,199    55,252    225,310    169,388 
Sales and marketing   469,225    143,762    1,376,636    564,360 
Research and development   408,118    317,626    1,099,053    950,744 
General and administrative   687,579    698,940    2,885,910    2,059,273 
Transaction costs   271,934    472,072    1,176,664    472,072 
Restructuring   –    334,360    –    334,360 
Depreciation and amortization   259,953    357,946    757,451    1,147,981 
Total operating expenses   2,201,008    2,379,958    7,521,024    5,698,178 
Loss from operations   (2,186,324)   (2,379,958)   (7,498,756)   (5,698,178)
                     
Other expense:                    
Interest income (expense)   73,067    (1,193)   128,680    (4,191)
Total other income (expense)   73,067    (1,193)   128,680    (4,191)
Loss before income taxes   (2,113,257)   (2,381,151)   (7,370,076)   (5,702,369)
Provision for income taxes   –    –    –    – 
Net loss  $(2,113,257)  $(2,381,151)  $(7,370,076)  $(5,702,369)
                     
Net loss per share attributable to common stockholders                    
Basic and diluted  $(0.36)  $(1.59)  $(2.11)  $(6.86)
                     
Weighted average common shares outstanding                    
Basic and diluted   5,803,182    194,659    3,496,049    107,927 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

  (1) The Company’s weighted average common stock outstanding for the three and nine months ended September 30, 2026 and 2025 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026.

 

 

 

 5 

 

Auddia Inc.

Condensed Statements of Changes in Stockholders’ Equity
for the Nine Months Ended September 30, 2026 and 2025

(Unaudited)

 

                                              
   Series B Preferred Stock  Series C Preferred Stock  Common Stock         
   Number of
Shares
  Par Value  Number of
Shares
  Par Value  Number of
Shares
  Par Value  Additional
Paid-In-Capital
  Accumulated
Deficit
  Total
Balance, December 31, 2025   –   $–    750   $1    402,833   $403   $101,518,433   $(97,283,343)  $4,235,494 
Issuance of common shares, net of costs   –    –    –    –    98,043    98    891,825    –    891,923 
Offering costs   –    –    –    –    –    –    (23,387)   –    (23,387)
Share-based compensation   –    –    –    –    –    –    14,897    –    14,897 
Capitalized dividends   –    –    –    –    –    –    30,323    (30,323)   – 
RSS adjustment   –    –    –    –    38    0    –    –    – 
Net loss   –    –    –    –    –    –    –    (2,281,553)   (2,281,553)
Balance, March 31, 2026   –   $–    750   $1    500,914   $501   $102,432,091   $(99,595,219)  $2,837,374 
Issuance of common shares   –    –    –    –    1,405,006    1,405    2,180,317    –    2,181,722 
Issuance of Pre-Funded Warrants   –    –    –    –    –    –    5,711,457    –    5,711,457 
Common Warrant   –    –    –    –    –    –    4,106,814    –    4,106,814 
Offering costs   –    –    –    –    –    –    (1,190,179)   –    (1,190,179)
Exercise of Pre-Funded Warrants into Common Stock   –    –    –    –    3,679,737    3,680    (3,680)   –    – 
Share-based compensation   –    –    –    –    –    –    15,087    –    15,087 
Series C Preferred Conversion   –    –    (750)   (1)   191,815    192    (191)   –    – 
Exercise of Common Warrants   –    –    –    –    1,000    1    2,359    –    2,360 
Conversion of Capitalized dividends into Common Shares   –    –    –    –    24,710    24    (24)   –    – 
Net loss   –    –    –    –    –    –    –    (2,975,266)   (2,975,266)
Balance, June 30, 2026   –   $–    –   $–    5,803,182   $5,803   $113,254,051   $(102,570,485)  $10,689,369 
Share-based compensation   –    –    –    –    –    –    15,342    –    15,342 
Net loss   –    –    –    –    –    –    –    (2,113,257)   (2,113,257)
Balance, September 30, 2026   –   $–    –   $–    5,803,182   $5,803   $113,269,393   $(104,683,742)  $8,591,454 

 

 

 

 

 6 

 

   Series B Preferred Stock  Series C Preferred Stock  Common Stock         
   Number of
Shares
  Par Value  Number of
Shares
  Par Value  Number of
Shares
  Par Value  Additional
Paid-In-Capital
  Accumulated
Deficit
  Total
Balance, December 31, 2024   2,314   $2    –   $–    51,653   $52   $94,122,702   $(89,428,436)  $4,694,320 
Issuance of common shares, net of costs   –    –    –    –    10,253    10    672,785    –    672,795 
Series B preferred stock converted to common stock   (140)   –    –    –    2,163    2    (139,012)   –    (139,010)
Offering costs   –    –    –    –    –    –    (55,120)   –    (55,120)
Share-based compensation   –    –    –    –    –    –    76,906    –    76,906 
Issuance of restricted stock units   –    –    –    –    25    –    (0)   –    – 
Capitalized dividends converted to common stock   –    –    –    –    2,163    2    139,574    –    139,576 
Capitalized dividends   –    –    –    –    –    –    58,758    (58,758)   – 
Net loss   –    –    –    –    –    –    –    (1,752,565)   (1,752,565)
Balance, March 31, 2025   2,174   $2    –   $–    66,257   $66   $94,876,593   $(91,239,759)  $3,636,902 
Issuance of common shares, net of costs   –    –    –    –    3,247    3    82,497         82,500 
Issuance of Series C preferred stock and warrants, net of issuance costs   –    –    750    1    –    –    699,999    –    700,000 
Series B preferred stock converted to common stock   (639)   (1)   –    –    15,552    16    (15)   –    – 
Share-based compensation   –    –    –    –    –    –    21,158    –    21,158 
Capitalized dividends   –    –    –    –    –    –    44,350    (44,350)   – 
RSS adjustment   –    –    –    –    4    –    –    –    – 
Net loss   –    –    –    –    –    –    –    (1,568,653)   (1,568,653)
Balance, June 30, 2025   1,535   $1    750  $1    85,060   $85   $95,724,582   $(92,852,762)  $2,871,907 
Issuance of common shares, net of costs                       125,974    126    3,612,030    –    3,612,156 
Preferred stock converted to common stock   (1,535)   (1)   –    –    67,607    67    (546)   –    (480)
Offering costs   –    –    –    –    –    –    (2,585)   –    (2,585)
Share-based compensation   –    –    –    –    –    –    92,984    –    92,984 
Warrant exercises   –    –    –    –    3,510    4    –    –    4 
Capitalized dividends   –    –    –    –    –    –    –    (28,750)   (28,750)
Net loss   –    –         –    –    –    –    (2,381,151)   (2,381,151)
Balance September 30, 2025   –   $–    750   $1    282,151   $282   $99,426,465   $(95,262,663)  $4,164,085 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

  (1) The Company’s common stock outstanding as of September 30, 2026 and 2025 and December 31, 2025 and 2024 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026.

 

 

 

 7 

 

Auddia Inc.

Condensed Statements of Cash Flows

(Unaudited)

           
   For the Nine Months Ended September 30, 
   2026   2025 
Cash flows from operating activities:          
Net loss  $(7,370,076)  $(5,702,369)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and amortization   757,451    1,147,982 
Share-based compensation expense   45,326    191,048 
Amortization of ROU asset   24,208    22,160 
Change in assets and liabilities:          
Accounts receivable   (243)   (274)
Prepaid assets   32,323    (59,603)
Other current assets   (15,874)   – 
Deferred revenue   3,115    – 
Accounts payable and accrued liabilities   (364,954)   85,697 
Lease liabilities   (28,024)   (20,453)
Net cash used in operating activities   (6,916,748)   (4,335,812)
           
Cash flows from investing activities:          
Issuance of loans   (1,175,269)   – 
Disposition of property and equipment   –    502 
Software capitalization   (776,546)   (512,277)
Intangibles capitalization   (10,138)   (22,237)
Net cash used in investing activities   (1,961,953)   (534,012)
           
Cash flows from financing activities:          
Offering costs   72,456    (178,192)
Repayments of debt   (60,520)   – 
Proceeds from issuance of preferred shares, net of issuance costs   –    700,000 
Proceeds from issuance of common shares, net of issuance costs   2,857,257    4,368,296 
Proceeds from issuance of Prefunded warrants, net of issuance costs   5,144,986    – 
Proceeds from issuance of common warrants, net of issuance costs   3,699,494    – 
Proceeds from exercise of common warrants   2,359    – 
Dividends and Series B preferred stock converted to common stock   –    567 
Net cash provided by financing activities   11,716,032    4,890,671 
           
Net increase in cash   2,837,331    20,847 
           
Cash, beginning of year   3,186,985    2,706,319 
           
Cash and restricted cash, end of period  $6,024,316   $2,727,166 
           
Supplemental disclosures of cash flow information:          
Cash paid for interest  $2,312   $4,442 
           
Supplemental disclosures of non-cash activity:          
Reclassification of deferred offering costs  $–   $57,705 
Capitalized dividends  $30,323   $131,858 
Dividends and preferred stock converted to common stock  $24   $354,007 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 

 8 

 

Auddia Inc.

Notes to Condensed Financial Statements (Unaudited)

 

 

Note 1 – Description of Business, Basis of Presentation and Summary of Significant Accounting Policies

 

Description of Business

 

Auddia Inc., (the “Company”, “Auddia”, “we”, “our”) is a technology company that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company is incorporated in Delaware and headquartered in Colorado.

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”).

 

Interim Financial Information

 

The condensed financial statements of the Company included herein have been prepared, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this Quarterly Report, as is permitted by such rules and regulations. The condensed balance sheet as of December 31, 2025 has been derived from the financial statements included in the Company’s annual report on Form 10-K. Accordingly, these condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K. The results for any interim period are not necessarily indicative of results for any future period. The Company recorded all adjustments necessary for a fair statement of the results for the interim period and all such adjustments are of a normal recurring nature.

 

Reverse Stock Splits

 

On March 28, 2025, the Company effectuated a 1-for-17 reverse stock split.

 

On March 31, 2026, the Company effectuated a 1-for-7.7 reverse stock split.

 

The reverse stock splits did not change the authorized number of shares of the Company’s common stock. No fractional shares were issued and any fractional shares resulting from the reverse stock splits were rounded up to the nearest whole share.

 

The reverse stock splits applied to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the reverse stock splits. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.

 

As a result of the reverse stock splits, unless described otherwise, all references to common stock, share data, per share data and related information contained in these financial statements have been retroactively adjusted to reflect the effect of the reverse stock splits for all periods presented. In addition, any fractional shares that would otherwise be issued as a result of the reverse stock splits were rounded up to the nearest whole share. Further, the number of shares issuable and exercise prices of stock options and warrants have been retrospectively adjusted in these financial statements for all periods presented to reflect the reverse stock splits.

 

 

 

 9 

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The condensed financial statements include some amounts that are based on management’s best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company’s common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.

 

Risks and Uncertainties

 

The Company is subject to various risks and uncertainties frequently encountered by companies in the early stages of development. Such risks and uncertainties include, but are not limited to, its limited operating history, competition from other companies, limited access to additional funds, dependence on key personnel, and management of potential rapid growth. To address these risks, the Company must, among other things, develop its customer base; implement and successfully execute its business and marketing strategy; develop follow-on products; provide superior customer service; and attract, retain, and motivate qualified personnel. There can be no guarantee that the Company will be successful in addressing these or other such risks.

 

Going Concern

 

Our existing cash and cash equivalents was $6,024,316 at September 30, 2026 which will only be sufficient to fund our current operating plans into the second quarter of 2027. The Company will need additional funding to complete the development of the full product line and scale products with a demonstrated market fit. The Company has plans to secure such additional funding. If the Company is unable to raise capital when needed or on acceptable terms, the Company would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern.

 

Cash and Cash Equivalents

 

The Company had cash on hand of $1,138,036 and $1,052,990 as of September 30, 2026 and December 31, 2025, respectively.

 

The Company considers all highly liquid instruments purchased with an original maturity of three months or less to be cash equivalents. The Company had cash equivalents of $4,886,280 and $2,133,995 as of September 30, 2026 and December 31, 2025, respectively. 

 

The Company maintains cash deposits at several financial institutions, which are insured by the Federal Deposit Insurance Corporation up to $250,000. The Company’s cash balance may at times exceed these limits. As of September 30, 2026, the Company had approximately $5.7 million in excess of federally insured limits. As of December 31, 2025, the Company had approximately $2.9 million in excess of federally insured limits. The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests.

 

Property and Equipment

 

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is provided utilizing the straight-line method over the estimated useful lives for owned assets, ranging from two to five years.

 

 

 

 10 

 

Software Development Costs

 

The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable.

 

The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies.

 

Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are considered impaired and expensed during the period of such determination. Software development costs of $224,624 and $35,802 were capitalized for the three months ended September 30, 2026 and 2025, respectively. Software development costs of $796,349 and $512,277 were capitalized for the nine months ended September 30, 2026 and 2025, respectively. Amortization of capitalized software development costs was $258,033 and $356,118 for the three months ended September 30, 2026 and 2025, respectively and $752,204 and $1,143,272 for the nine months ended September 30, 2026 and 2025, respectively, and are included in depreciation and amortization expense in the Company’s condensed statement of operations.

 

Long-Lived Assets

 

The Company reviews its tangible and limited lived intangible long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered. If a potential impairment is indicated, the Company compares the carrying amount of the asset to the undiscounted future cash flows associated with the asset. In the event the future cash flows are less than their carrying value, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. The Company determined long-lived assets were not impaired for the nine months ended September 30, 2026 and 2025 and year ended December 31, 2025.

 

Income Taxes

 

The Company accounts for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events. A valuation allowance is established to reduce deferred tax assets to their estimated realizable value when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be realized in the future.

 

The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to unrecognized tax benefits as a part of income tax expense.

 

Prior to the Company’s conversion to a Delaware corporation in February 2021, the Company was a limited liability company and had elected to be treated as a pass-through entity for income tax purposes. Accordingly, taxable income and losses of the Company were reported on the income tax returns of its members, and no provision for federal income taxes have been recorded in the accompanying financial statements. Had the Company been a taxable entity, no provision for income taxes would have been recorded as the Company has sustained losses since inception.

 

Right of Use Assets and Lease Liabilities

 

In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). The standard requires lessees to recognize almost all leases on the balance sheet as a Right-of-use (“ROU”) asset and a lease liability and requires leases to be classified as either an operating or a finance type lease. The standard became effective for the Company beginning January 1, 2019. The Company adopted ASC 842 using the modified retrospective approach, by applying the new standard to all leases existing at the date of initial application. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under ASC 842.

 

 

 

 11 

 

Under ASC 842, the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company’s lease does not provide an implicit rate, the Company estimated the incremental borrowing rate in determining the present value of lease payments.

 

Operating leases are included in operating lease right of use asset and operating lease liabilities, current and non-current, on the Company’s accompanying balance sheets.

 

Revenue Recognition

 

Revenue is measured according to Accounting Standards Codification (“ASC”) 606, Revenue – Revenue from Contracts with Customers, and is recognized based on consideration specified in a contract with a customer and excludes any sales incentives and amounts collected on behalf of third parties. The Company recognizes revenue when it satisfies a performance obligation by transferring control over a service or product to a customer. To achieve this core principle, the Company applies the following five steps: (1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the company satisfies a performance obligation. The Company reports revenues net of any tax assessed by a governmental authority that is both imposed on, and concurrent with, a specific revenue-producing transaction between a seller and a customer in the accompanying statements of operations. Collected taxes, if applicable, are recorded within other current liabilities until remitted to the relevant taxing authority.

 

Subscriber revenue consists primarily of subscription fees and other ancillary subscription-based revenues. Revenue is recognized on a straight-line basis when the performance obligations to provide each service for the period have been satisfied, which is over time as our subscription services are continuously available and can be consumed by customers at any time. There is no revenue recognized for unpaid trial subscriptions.

 

Customers may pay for the services in advance of the performance obligation and therefore these prepayments are recorded as deferred revenue. The deferred revenue is recognized as revenue in the accompanying statements of operations as the services are provided.

 

Advertising Costs

 

The Company expenses advertising costs as incurred. Advertising expense for the three months ended September 30, 2026 and 2025 was $282,613 and $9,840, respectively. Advertising expense for the nine months ended September 30, 2026 and 2025 was $699,622 and $153,079, respectively.

 

Share-Based Compensation

 

The Company accounts for share-based compensation arrangements with employees, directors, and consultants and recognizes the compensation expense for share-based awards based on the estimated fair value of the awards on the date of grant.

 

Compensation expense for all share-based awards is based on the estimated grant-date fair value and recognized in earnings over the requisite service period (generally the vesting period). The Company records share-based compensation expense related to non-employees over the related service periods.

 

Emerging Growth Company Status

 

The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with certain new or revised accounting standards that have different effective dates for public and private companies.

 

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of: (i) the last day of the fiscal year (a) following the fifth anniversary of the completion of our IPO, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30th, and (ii) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.

 

Based on these criteria, the Company’s emerging growth company status is currently expected to expire on December 31, 2026, unless it earlier meets one of the disqualifying conditions described above.

 

 

 

 12 

 

Note 2 – Property & Equipment, Intangible Assets, and Software Development Costs

 

Property and equipment and software development costs consisted of the following as of:

      
   September 30, 2026  December 31, 2025
       
Computers and equipment  $102,125   $102,125 
Furniture   11,258    11,258 
Accumulated depreciation   (109,301)   (106,713)
Total property and equipment, net  $4,082   $6,670 
           
Domain name  $3,947   $3,947 
Patents   33,931    23,596 
Accumulated amortization   (4,613)   (1,758)
Total intangible assets, net  $33,265   $25,785 
           
Software development costs  $10,206,333   $9,429,985 
Accumulated amortization   (8,573,172)   (7,821,166)
Total software development costs, net  $1,633,161   $1,608,819 

 

The Company recognized depreciation expense of $783 and $1,409 for the three months ended September 30, 2026 and 2025, respectively, related to property and equipment, amortization expense of $1,138 and $420 for the three months ended September 30, 2026 and 2025, respectively, related to intangible assets, and amortization expense of $258,033 and $356,118 for the three months ended September 30, 2026 and 2025, respectively, related to software development costs.

 

The Company recognized depreciation expense of $2,589 and $4,105 for the nine months ended September 30, 2026 and 2025, respectively, related to property and equipment, amortization expense of $2,658 and $605 for the nine months ended September 30, 2026 and 2025, respectively, related to intangible assets, and amortization expense of $752,204 and $1,143,272 for the nine months ended September 30, 2026 and 2025, respectively, related to software development costs.

 

Note 3 – Related Party Transactions

 

Jeffrey Thramann, the Company's Chief Executive Officer and Executive Chairman, is the sole member of Thramann Holdings, LLC and controls its subsidiaries, LT350, LLC, Influence Healthcare, LLC, and Voyex, LLC (together, the "Thramann Entities"). The Company has entered into a Merger Agreement with Thramann Holdings, LLC.

 

Interim Bridge Funding for Target Companies

 

On July 17, 2026, Auddia entered into a senior unsecured bridge note (each a “Bridge Note”) with each of Thramann Holdings, LT350, Influence, and Voyex. The purpose of the Bridge Notes is to provide a limited amount of interim funding and working capital to the Thramann Entities while the Merger Agreement is still pending.

 

The Bridge Notes were reviewed and approved by Auddia’s special committee of independent and disinterested directors (the “Special Committee”) and Audit Committee.

 

Terms of the Bridge Notes

 

Amount and Funding

 

The maximum amount to be funded by Auddia under each of the Bridge Notes is up to (i) $360,000 for Thramann Holdings, (ii) $400,000 for LT350; (iii) $590,000 for Influence Healthcare; and (iv) $50,000 for Voyex. Amounts will be funded in tranches as mutually agreed to by the parties. Any advance in excess of $50,000 will require approval of the Auddia’s Audit Committee. No further amounts will be funded if the pending Merger Agreement is terminated. As of September 30, 2026, the aggregate funded amount was $1,175,269.

 

On October 16, 2026, the terms of the Bridge Notes were amended. Under this amendment, the maximum amount to be funded by Auddia under each of the Bridge Notes was increased to (i) up to $420,000 for Thramann Holdings, (ii) up to $1,900,000 for LT350; (iii) up to $900,000 for Influence Healthcare; and (iv) up to $85,000 for Voyex.

 

 

 

 13 

 

Interest Rate; Maturity Date

 

Interest shall accrue at the rate of 8.0% per annum, compounded annually.

 

Unless earlier repaid or converted, outstanding principal and unpaid accrued interest on each Bridge Note shall be due and payable upon the earlier of (i) the second anniversary of the termination of the Merger Agreement or (ii) a change of control (as defined in the Bridge Notes) involving a particular Thramann Entity. In the event of a change of control involving LT350, Influence or Voyex, the particular Thramann Entity would owe a repayment premium equal to 50% of the outstanding principal amount of its Bridge Note.

 

Seniority and Security

 

The Bridge Notes are unsecured senior obligations of each Thramann Entity. Each Thramann Entity has agreed not to incur any debt that would be secured or senior to its Bridge Note.

 

Conversion Terms

 

The Thramann Holdings Bridge Note is not convertible.

 

If any of the other Thramann Entities consummates, on or prior to its Bridge Note maturity date, an equity financing pursuant to which it sells shares of its equity securities (the “Next Round Securities”), with an aggregate sales price of not less than the amount set forth below, excluding any and all indebtedness under the Bridge Note that is converted into Next Round Securities, and with the principal purpose of raising capital (a “Qualified Financing”), then all principal, together with all unpaid accrued interest under the particular Bridge Note, shall automatically convert into shares of the Next Round Securities at 80% of the cash price per share paid by the other purchasers of Next Round Securities in the Qualified Financing. The Qualified Financing threshold shall be (i) $3,000,000 for LT350; (ii) $2,000,000 for Influence; and $1,000,000 for Voyex.

 

Credit of Funds for Cash Merger Closing Condition

 

The Merger Agreement contains a closing condition that Auddia’s net cash at closing be at least equal to $12,000,000. The parties have agreed that any funds advanced by Auddia to the Target Companies under the Bridge Notes shall be credited to Auddia’s net cash at closing for purposes of this closing condition under the Merger Agreement.

 

The above summary of the Bridge Notes does not purport to be a complete summary of the Bridge Notes and is qualified in its entirety by reference to the full text of each of the Bridge Notes, copies of which are filed herewith as an exhibit and are incorporated by reference.

 

The Company accounts for the Bridge Notes as related-party notes receivable held for investment at amortized cost. Management evaluated the embedded features of the Bridge Notes under ASC 815 and concluded that the conversion features do not require bifurcation as a result of the low probability due to the merger agreement non-solicitation in place.

 

Expenses incurred for the benefit of related parties.

 

During the three and nine months ended September 30, 2026, the Company incurred $108,642 of expenses paid to third parties for services that benefited the Thramann Entities, consisting of commercial partnership development services for LT350, legal fees and board fees related to the LT350 board, and advisory and presentation services to evaluate funding for the Thramann Entities. The Company has not been reimbursed for these expenses, which are included in operating expenses. No such expenses were incurred during the three and nine months ended September 30, 2025. These arrangements were reviewed and approved by the Special Committee and the Audit Committee.

 

Note 4 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consist of the following:

      
   September 30, 2026  December 31, 2025
       
Accounts payable  $243,030   $577,774 
Accrued liabilities   243,407    275,580 
Credit cards payable   1,963    – 
   $488,400   $853,354 

 

 

 

 14 

 

Note 5 – Notes Payable

 

On June 20, 2025, the Company entered into a promissory note to finance its directors and officers (“D&O”) insurance premium. The original principal amount of the note was $151,300 and bore interest at a fixed annual rate of 8.250%. The note required monthly payments of principal and interest and matured on May 20, 2026. The note has been fully paid down.

 

As of September 30, 2026 and December 31, 2025, the outstanding principal balance was $0 and $60,520, respectively. The note was unsecured and contained no financial covenants.

 

Note 6 – Commitments and Contingencies

 

Operating Lease

 

On March 25, 2024, the Company entered into a 37-month operating lease commencing on April 1, 2024 with two separate two year renewal options. The monthly base rent for months two through 14 is $2,456, increasing to $3,070 for months 15 through 26, and ending at $3,684 for months 27 through 37. Rent expense, as part of general and administrative expenses in the statements of operations, was $20,983 and $8,960 for the three months ended September 30, 2026 and 2025, respectively and $63,166 and $26,881 for the nine months ended September 30, 2026 and 2025, respectively.

 

Litigation

 

In the normal course of business, the Company is party to litigation from time to time. The Company maintains insurance to cover certain actions and believes that resolution of such litigation will not have a material adverse effect on the Company. There are no active litigations as of the date the financial statements were issued. However, a pre-IPO investor has contacted the Company claiming damages caused by alleged acts and omissions arising from a private financing by the Company. No complaint has been filed by the investor. The alleged damages asserted by the investor are less than approximately $300,000. The outcome of the complaint was neither probable nor reasonably estimable as of the date the financial statements were issued, therefore, no accrual has been made.

 

In addition, one investor in our April 2026 common stock and warrant public offering has contacted the Company claiming that it would be owed a cash payment for warrants it holds if the Company’s proposed merger with Thramann Holdings LLC is consummated. We believe this investor’s claim is without merit because all warrants expire in accordance with their terms prior to the consummation of the Company’s pending merger. No complaint has been filed by this investor. If a complaint is filed, the Company believes it would have meritorious defenses to this claim and would intend to defend such case vigorously. The outcome of the claim was neither probable or estimable as of the date that these financial statements were issued. Therefore, no accrual has been made.

 

Note 7 – Share-based Issuances

 

Stock Options

 

The fair value of each option award is estimated on the date of grant using a Black Scholes option valuation model that uses the assumptions noted in the following table. Because Black Scholes option valuation models incorporate ranges of assumptions for inputs, these ranges are disclosed. Expected volatilities and based on implied volatilities from traded options on the Company’s stock, historical volatility of the Company’s stock, and other factors. The expected term of options granted is derived from the output of the valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

 

 

 15 

 

The following table presents the activity for stock options outstanding:

      
   Options  Weighted Average Exercise Price
Outstanding - December 31, 2025   17,640   $79.66 
Granted   –    – 
Forfeited/canceled   –    – 
Exercised   –    – 
Outstanding – September 30, 2026   17,640   $79.66 

         
   Options   Weighted Average Exercise Price 
Outstanding - December 31, 2024   4,480   $953.88 
Granted   13,564    14.94 
Forfeited/canceled   (92)   9,104.02 
Exercised   –    – 
Outstanding – September 30, 2025   17,952   $203.43 

 

The following table presents the composition of options outstanding and exercisable:

           
   Options Outstanding**      Options Exercisable** 
Exercise Prices  Number   Price   Life*  Number   Price* 
$14.94   13,564   $14.94   8.95   7,291   $14.94 
$66.75   3,821   $66.75   8.26   3,821   $66.75 
$818.13   144   $818.13   7.71   71   $818.13 
$1,295.91   16   $1,295.91   6.69   12   $1,295.91 
$5,857.78   43   $5,857.78   5.38   43   $5,857.78 
$9,130.28   20   $9,130.28   4.87   20   $9,130.28 
$9,475.72   16   $9,475.72   1.34   16   $9,475.72 
$13,927.65   16   $13,927.65   2.88   16   $13,927.65 
Total -September 30, 2026   17,640            11,290      

 

* Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.
** The Company’s common stock outstanding as of September 30, 2026 and December 31, 2025 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026.

 

Restricted Stock Units

 

The following table presents the activity for restricted stock units outstanding:

      
  

Restricted Stock

Units

 

Weighted Average

Grant Date

Fair Value

Outstanding - December 31, 2024   40   $7,398.47 
Granted   –    – 
Forfeited/canceled   4    – 
Exercised   (44)   7,398.47 
Outstanding – September 30, 2025   –   $– 

 

The Company recognized share-based compensation expense related to stock options and restricted stock units of $15,342 and $92,984 for the three months ended September 30, 2026 and 2025, respectively and $45,326 and $191,048 for the nine months ended September 30, 2026 and 2025. The remaining unamortized share-based compensation expense of $125,336 is expected to be recognized over the next 36 months.

 

 

 

 16 

 

Note 8 – Equity Financings

  

Equity Line Common Stock Purchase Agreement

 

On November 25, 2024, the Company entered into a new equity line Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the Common Stock Purchase Agreement, the Company has the right, but not the obligation to require White Lion to purchase, from time to time, up to $10,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. On July 30, 2025, the Company amended the equity line Common Stock Purchase Agreement from $10,000,000 to $50,000,000 and extended the commitment to December 31, 2027.

 

During the year ended December 31, 2025, the Company issued 129,221 shares of Common stock under the Equity Line Common Stock Purchase Agreement for total proceeds of $3.7 million.

 

At-the-Market Sales Agreement

 

The Company has entered into an At-the-Market Issuance Sales Agreement (the “Sales Agreement”) with Ascendiant Capital Markets, LLC, as sales agent (the “Agent”). Under the Sales Agreement, the Company may sell shares of its common stock having an aggregate offering price of up to $10,000,000 from time to time, through an “at the market offering” (the “ATM Offering”). The aggregate market value of shares that the Company can sell under the Sales Agreement will be subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction.

 

During the three and nine months ended September 30, 2026, the Company sold 0 and 98,043 shares, respectively under the Sales Agreement for proceeds of $0.9 million and currently has $0.0 million of unsold availability under the ATM facility.

 

During the year ended December 31, 2025, the Company issued 130,879 shares under the Sales Agreement for aggregate proceeds of approximately $2.8 million under the ATM facility.

 

$2.3 Million Convertible Series B Preferred Stock and Warrants Financing

 

On April 23, 2024, the Company entered into a securities purchase agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $2,314,000 of gross proceeds in connection with the closing of this financing.

 

At the closing, the Company issued 2,314 shares of Series B convertible preferred stock (“Series B Preferred Stock”) at a purchase price of $1,000 per share of Series B Preferred Stock. The Series B Preferred Stock is convertible into Common Stock at an initial conversion price (“Conversion Price”) of $242.32 per share of Common Stock. The Company also issued warrants (“Warrants”) exercisable for 9,552 shares of Common Stock with a five-year term and an initial exercise price of $242.32 per share, which has been subsequently adjusted to $2.36. The proceeds of this financing, together with other available cash resources, were used to repay outstanding debt and for general corporate purposes.

 

Holders of the Series B Preferred Stock will be entitled to dividends in the amount of 10% per annum, payable quarterly. The Company has the option to pay dividends on the Series B Preferred Stock in additional shares of Common Stock. The Company also has the option to cumulate or “capitalize” the dividends, in which case the accrued dividend amount shall be added to the stated value of each share of Series B Preferred Stock.

 

On February 19, 2025, 140 shares of Series B Preferred stock and capitalized dividends were converted to 4,326 shares of Common Stock.

 

In April 2025, 447 shares of Series B Preferred stock and capitalized dividends were converted to 11,069 shares of Common stock.

 

 

 

 17 

 

On June 26, 2025, 192 shares of Series B Preferred stock and capitalized dividends were converted to 4,484 shares of Common Stock.

 

On August 5, 2025, the Company entered into a series of exchange agreements (the “Exchange Agreements”) with certain accredited investors to exchange 569 outstanding shares of the Company’s Series B preferred stock (including accrued dividends thereon) for 17,237 shares of common stock at an exchange price of $20.41 per common share. The issuance of the exchange common shares is intended to be exempt from registration pursuant to the exemptions under Section 3(a)(9) of the Securities Act of 1933, as amended (the “Securities Act”).

 

As of September 30, 2026, no shares of Series B Preferred stock remain outstanding.

 

$750,000 Series C Preferred Stock and Warrants Financing

 

On June 30, 2025, the Company entered into a Securities Purchase Agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $750,000 of gross proceeds in connection with the closing of this financing.

 

At the closing, the Company issued 750 shares of Series C convertible preferred stock (“Series C Preferred Stock”) at a purchase price of $1,000 per share of Series C Preferred Stock. The Series C Preferred Stock is convertible into Common Stock at an initial conversion price (“Series C Conversion Price”) of $36.73 per share of Common Stock. The Company also issued warrants exercisable for 40,841 shares of Common Stock with a five year term and an initial exercise price of $36.73 per share, which has been subsequently adjusted to $2.36.

 

On April 23, 2026, the Company entered into an exchange agreement (the “Exchange Agreement”) with the accredited investors to exchange 750 outstanding shares of the Company’s Series C preferred stock plus capitalized dividends to date for 216,525 shares of common stock at an exchange price of $3.91 per common share. No shares of Series C preferred stock remain outstanding.

 

As of September 30, 2026, no shares of Series C Preferred stock remain outstanding.

 

The proceeds of this financing, together with other available cash resources, will be used for general corporate purposes.

 

April 2026 Registered Direct Offering

 

On April 27, 2026, the Company closed a best-efforts registered direct offering (the “Offering”) of 1,405,006 shares of common stock, together with, in lieu of common stock for certain investors, 3,679,737 pre-funded warrants to purchase common stock (the “Pre-Funded Warrants”), and accompanying common stock purchase warrants to purchase up to 5,084,743 shares of common stock (the “Common Warrants”). The combined public offering price was $2.36 per share (or per Pre-Funded Warrant) and accompanying Common Warrant. Gross proceeds were $11,999,993 (approximately $12.0 million), before deduction of a 7.0% cash fee payable to the placement agent and other offering expenses, together totaling approximately $1.2 million. Gross proceeds were allocated among the common stock, pre-funded warrants and common warrants on a relative fair value basis.

 

The Pre-Funded Warrants have an exercise price of $0.001 per share, which was pre-funded at closing, and no stated expiration date; they remain exercisable until exercised in full. The Common Warrants have an exercise price of $2.36 per share and expire earlier of (i) five years from the initial exercise date and (ii) the consummation of the Company’s pending merger with Thramann Holdings, LLC (the “Merger”). All 3,679,737 Pre-Funded Warrants were exercised by April 30, 2026 for an aggregate exercise price of $3,680. As of September 30, 2026, 1,000 common warrants were exercised at $2.36 with the proceeds of $2,360, leaving 5,083,743 Common Warrants outstanding.

 

The Company evaluated the Common Warrants and Pre-Funded Warrants under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and determined that both instruments are indexed to the Company’s own stock and meet the criteria for equity classification. Accordingly, the warrants have been classified within stockholders’ equity and are not subject to fair value remeasurement in future periods.

 

 

 

 18 

 

All 3,679,737 Pre-Funded Warrants were exercised in full as of September 30, 2026. Upon exercise, $5,711,457 was reclassified from the Pre-Funded Warrants equity account to common stock and additional paid-in capital. No Pre-Funded Warrants remain outstanding.

 

Warrant Valuation

 

The Company estimated the fair value of the Common Warrants issued in the Offering on the issuance date using the Black-Scholes option-pricing model. The fair value of the Pre-Funded Warrants approximated their intrinsic value due to the nominal exercise price of $0.001 per share and was recorded within stockholders’ equity. The assumptions used in estimating the fair value of the Common Warrants were based on information available at the issuance date. Because the Common Warrants and Pre-Funded Warrants met the criteria for equity classification under ASC 815-40, the warrants were recorded in stockholders’ equity and are not subsequently remeasured.

 
Assumption Common Warrants
Valuation methodology Black-Scholes option-pricing model
Stock price $1.50
Exercise price $2.36
Risk-free rate 3.71%
Volatility 150%
Expected term (in years) 1.28
Dividend yield 0.00%

 

The expected term reflects management’s estimate of the period until exercise or termination, including consideration of the pending merger transaction and the contractual provision causing the warrants to expire upon consummation of the merger.

 

Warrants

 

The following table presents the activity for warrants outstanding:

      
   Warrants  Weighted Average Exercise Price
Outstanding - December 31, 2025   54,699   $9.10 
Granted   8,764,480    2.36 
Forfeited/canceled   –    – 
Exercised   (3,680,737)   2.36 
Outstanding – September 30, 2026   5,138,442   $2.36 

 

   Warrants  Weighted Average Exercise Price
Outstanding - December 31, 2024   18,560   $980.29 
Granted   51,701    36.73 
Forfeited/canceled   –    – 
Exercised   (3,510)    20.41 
Outstanding – September 30, 2025   66,751   $299.95 

 

During the nine months ended September 30, 2026 and year ended December 31, 2025, in connection with the Series C Preferred Stock Issuance, the Company issued 0 and 40,840, respectively warrants to purchase shares of common stock at the exercise price of $36.73. The per share exercise price has been adjusted to $2.36.

 

 

 

 

 19 

 

Note 9 – Leases under ASC 842

 

The Company leases certain office space under operating leases for use in operations. The Company recognizes operating lease expense on a straight-line basis over the lease term. Management determines if an arrangement is a lease at contract inception. Lease and non-lease components are accounted for as a single component for all leases. Operating lease right to use (“ROU”) assets and liabilities are recognized at the lease commencement date based on the present value of the future lease payments over the expected lease term, which includes optional renewal periods if the Company determines it is reasonably certain that the option will be exercised. As the operating lease does not provide an implicit rate, the discount rate used in the present value calculation represents the incremental borrowing rate determined using information available at the commencement date. Rent expense, as part of general and administrative expenses in the statements of operations, was $20,983 and $8,960 for the three months ended September 30, 2026 and 2025, respectively and $63,166 and $26,881 for the nine months ended September 30, 2026 and 2025, respectively. As of September 30, 2026, weighted-average remaining lease term and discount rate were as follows:

   
   September 30, 2026
Weighted-average remaining lease term   0.50 year 
Weighted-average discount rate   8.6% 

 

The following is a maturity analysis of the annual undiscounted cash flows reconciled to the carrying value of the operating lease liabilities as of September 30, 2026:

Schedule of annual undiscounted cash flows of leases   
Years Ended December 31,   
2026  $11,051 
2027   14,735 
Less imputed interest   (723)
Total  $25,063 

 

Note 10 – Segment Reporting

 

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the Chief Operating Decision Maker (“CODM”) in making decisions regarding resource allocation and assessing performance.

 

The Company has one operating segment, which is also its only reportable segment engaged in the technology of how customers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. The Company’s Chief Financial Officer (“CFO”), as the CODM, regularly reviews the entity-wide financial and operational performance as a single unit. No financial information is disaggregated into separate lines of businesses. The CFO makes resource allocation and business process decisions regarding the overall level of resources available and how to best deploy these resources.

 

The single segment’s principal measure of segment profit and loss is consolidated research and development expenses and administrative expenses. The CFO considers actual and forecasted expenses when evaluating performance.

 

Note 11 – Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss, which is allocated based upon the proportionate amount of weighted average shares outstanding, to each class of stockholder’s stock outstanding during the period. For the calculation of diluted net loss per share, net loss per share attributable to common stockholders for basic net loss per share is adjusted by the effect of dilutive securities, including awards under our equity compensation plans.

 

 

 

 20 

 

As of September 30, 2026 and September 30, 2025, 5,156,082 and 122,868, respectively are potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented.

 

The shares underlying the Pre-Funded Warrants are included in basic weighted-average shares outstanding from the April 27, 2026 issuance date because the Pre-Funded Warrants are exercisable for nominal consideration and are not subject to any contingency other than the passage of time. The Common Warrants are excluded from basic earnings per share and are evaluated each period for their dilutive effect using the treasury stock method (or a method that reflects the Common Warrant’s cash-settlement feature); given the Company’s net losses, the Common Warrants were antidilutive and excluded from diluted earnings per share for the periods presented.

 

Note 12 – Subsequent Events

 

Amendment to Interim Bridge Funding for Thramann Entities

 

As described above in Note 3, on October 16, 2026, the terms of the Bridge Notes between the Company and the Thramann Entities were amended. Under this amendment, the maximum amount to be funded by Auddia under each of the Bridge Notes was increased to (i) up to $420,000 for Thramann Holdings, (ii) up to $1,900,000 for LT350; (iii) up to $900,000 for Influence Healthcare; and (iv) up to $85,000 for Voyex. The purpose of the Bridge Notes Addendums is to provide an incremental amount of interim funding and working capital to the Thramann Entities while the Merger Agreement is still pending.

 

The Bridge Notes amendments were reviewed and approved by a Auddia’s special committee of independent and disinterested directors (the “Special Committee”) and Audit Committee.

 

Warrant Exchange

 

On November 6, 2026, Auddia Inc. entered into warrant exchange agreements with certain holders of its outstanding warrants. Under the terms of the agreements, holders agreed to exchange each outstanding warrant for two shares of the Company's common stock in a transaction exempt from registration under Section 3(a)(9) of the Securities Act of 1933.

 

Pursuant to the agreements, an initial 580,023 warrants were exchanged for 1,160,045 shares of common stock. In addition, subject to obtaining the requisite stockholder approval under Nasdaq listing requirements, an additional 4,135,539 warrants would be exchanged for an additional 8,271,077 shares of common stock. Until stockholder approval is obtained, the remaining warrants will continue to be outstanding in accordance with their existing terms.

 

 

 

 21 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis should be read in conjunction with the unaudited condensed financial statements and related notes included elsewhere in this Quarterly Report and our audited financial statements and related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC on March 6, 2026. This discussion and analysis and other parts of this Quarterly Report contain forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions, such as statements regarding our plans, objectives, expectations, intentions and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under Part II, Item 1A, “Risk Factors” and elsewhere in this Quarterly Report. You should carefully read the “Risk Factors” section of this Quarterly Report and of our Annual Report on Form 10-K for the year ended December 31, 2025, to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section entitled “Special Note Regarding Forward-Looking Statements.”

 

Overview

 

Auddia (the “Company”) is an AI technology company headquartered in Boulder, CO that is reinventing how consumers engage with audio through the development of its faidr app, an industry-first audio platform, which utilizes proprietary AI technology to personalize and customize both radio and podcast listening experiences and Discovr Radio, a web-based portal that allows artists and record labels to promote songs on radio streams, through an integration with the free faidr app.

 

faidr historically allowed users to listen to AM/FM radio stations without unwanted commercial breaks. The app replaces these ad breaks in real time with songs supplied by Discovr Radio, giving artists exposure on mainstream airwaves. The faidr app represents the first-time consumers can combine the local content uniquely provided by AM/FM radio with commercial-free and personalized listening many consumers demand from digital-media consumption and preference-based new music discovery.

  

The combination of AM/FM streaming and new-music distribution, with Auddia’s unique, AI technology-driven differentiators, addresses large (radio streamers) and rapidly growing (independent and emerging artists) audiences and customer bases.

 

We have developed our AI platform on top of Google’s TensorFlow open-source library that is being “taught” to know the difference between all types of audio content on the radio. For instance, the platform recognizes the difference between a commercial and a song and DJ conversation. Not only does the technology learn the differences between the various types of audio segments, but it also identifies the beginning and end of each piece of content.

 

The faidr app with its advanced features allow users to skip any content heard on the station and request audio content on-demand. We believe the faidr App represents a significant differentiated audio streaming product, the first to give audio streamers a more personalized middle ground between passive content like broadcast radio and fully on-demand content like Spotify. No other audio streaming app available today, including category leaders like TuneIn, iHeart, and Audacy, can compete with faidr’s full product offerings.

 

We launched an MVP version of faidr through several consumer trials in 2021 to measure consumer interest and engagement with the App. The full app launched on February 15, 2022, and included all major U.S. radio stations in the US. In February 2023, we added faidrRadio, our exclusive content offerings, to the app. Podcasts were added to the app for the iOS version before the end of Q1 2023 and added to the Android app in May of 2023.

 

The Company initially launched faidr with a B2C subscription model in February of 2022 and fully transitioned to a B2B subscription model in Q1 of 2026 after announcing its intentions to transition in August of 2025.

 

 

 

 22 

 

The Company’s new B2B business represents a strategic shift to AI driven music discovery. Auddia targets artists, labels, distributors, and managers for SaaS subscription access to ad-free AM/FM streaming listeners on the faidr app, while faidr users will enjoy free access to AI driven ad-free AM/FM streams on all music stations. Consumer subscriptions are no longer required to enjoy faidr’s ad-free and content personalization listening experience.

 

New music platforms like Bandcamp and SoundCloud are integral tools for artists to connect with new fans and even monetize their content, but those platforms only cater to a subset of the total addressable market for an artist. The Company believes the largest group of potential fans for most artists remains on commercial radio, listening to music passively and not searching for new artists even though Company surveys and research indicate radio listeners are interested in hearing new music when listening to their favorite radio stations. Auddia’s new Discovr Radio platform delivers the experience of passively listening to commercial AM/FM radio streams while passively being exposed to new music instead of radio ads.

 

Unlike other new music discovery platforms, which allow artists to upload songs in the hopes that new listeners will find them among the other songs available, Discovr Radio delivers guaranteed plays to artists, leveraging AI to place their songs into radio feeds as part of a custom programming experience and as unique content during what would typically be an ad break. This gives artists opportunities to be heard by the many millions of streaming radio listeners worldwide.

 

The Discovr Radio platform consists of a new AI Placement Engine and Artist Portal. The AI Placement Engine puts the right new song in front of the right listener, on the right station, adjacent to the right artist, to optimize music discovery and the connection between artists and fans. The Artist Portal gives artists performance analytics on number of total plays, likes and dislikes, demographic data, and facilitate the connection of artists to their new fans. In addition to streaming songs on live radio streams, the Discovr Radio offering allows artists, managers and labels leverage analytics to support their own pitches for editorial placements, terrestrial radio play, and many other opportunities within the music industry.

 

Auddia evolved its business model from direct-to-consumer to business-to-business, shifting its focus from individual radio-streaming subscribers to artists and labels as subscribers. Through a modest monthly subscription, artist and label customers gain guaranteed radio plays—offering a new channel for music promotion.

 

The faidr mobile App is available today through the iOS and Android App stores. The Discovr Radio platform was released on January 20, 2026, and fully launched with self-serve sign up and two tiers of monthly subscriptions in June of 2026.

 

Since the release of Discovr Radio, participating artists are seeing an average of 100 plays over radio per week, and the platform has delivered more than 550,000 total plays across all customers. In addition to plays and likes, faidr users have been engaging with artists through visits to artists pages and clicking on outbound links. As of November 11, 2026, artist pages are seeing an average 50% clickthrough rate, meaning half of all artist-page visits results in a user clicking to listen to the artist’s full library elsewhere, or following them on socials, or buying the artist’s merchandise, tickets, or music.

 

We have funded our operations with proceeds from the February 2021 IPO, Series A warrants exercised in July 2021 and common share issuance during June of 2023. We also obtained debt financing through a related party during November 2022 and April 2023, which was subsequently repaid in April 2024. In addition, we sold common shares during 2025 and 2024 pursuant to our equity line facility and issued preferred stock in our Series B and Series C issuances. Since our inception, we have incurred significant operating losses. In April 2026, we raised approximately $12.0 million before offering expenses of around $1.2 million. As of September 30, 2026, we had an accumulated deficit of $104,683,742. Our ability to generate product revenue sufficient to achieve profitability will depend heavily on the successful development and commercialization of one or more of our Apps. We expect that our expenses and capital requirements will increase substantially in connection with our ongoing activities, particularly if and as we:

 

· Scale and grow Discovr Radio with artists and labels and market our faidr App to consumers;
· continue to develop and expand our technology and functionality to advance the faidr app and Discovr Radio platform;
· rollout our product on an international basis, which will include increasing our sales and marketing costs related to the promotion of our products. faidr and Discovr Radio promotion will include a combination of a) purchasing ads directly from broadcasters or b) participating broadcasters to promote without purchasing ads, but sharing a portion of subscription proceeds based on listening activity on those stations or c) leveraging all social media outlets;
· continue to pursue and complete potential acquisitions of other companies;
· hire additional business development, product management, operational and marketing personnel;
· continue market studies of our products; and
· add operational and general administrative personnel which will support our product development programs, commercialization efforts and our transition to operating as a public company.

 

 

 

 23 

 

As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, which may include collaborations with other companies or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates.

 

Because of the numerous risks and uncertainties associated with product development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.

 

As of September 30, 2026, we had cash and cash equivalents of $6,024,316. During 2026 through September 30, 2026, we have secured approximately $12.9 million in additional financing in 2026. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. However, if we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

Recent Developments

 

Proposed Business Combination

 

On August 5, 2025, the Company issued a press release announcing that it had entered into a non-binding letter of intent (“LOI”) for a proposed business combination between the Company and Thramann Holdings, LLC (“Holdings”). Holdings is a privately held holding company that controls LT350, Influence Healthcare, and Voyex, three early stage AI-native companies founded by Jeff Thramann, Auddia’s founder, CEO and Executive Chairman.

 

The Company has established a special committee of the board of directors to evaluate the related party transaction. The special committee has engaged its own counsel and financial advisor.

 

On February 17, 2026, Auddia, acting upon the recommendation of its special committee of independent directors, entered into a definitive merger agreement for a business combination between Auddia and Thramann Holdings.

 

Upon closing of the proposed transaction, the Company would be renamed McCarthy Finney and would trade under its new MCFN ticker symbol. Auddia would become a wholly owned subsidiary of McCarthy Finney, and each of the three Thramann Holdings entities would also be wholly owned by McCarthy Finney. Jeff Thramann would remain as CEO of McCarthy Finney and John Mahoney would remain as CFO. Auddia’s current board members are expected to continue as members of the board of the combined company.

 

Auddia shareholders at the time of closing are expected to own a 20% economic interest of McCarthy Finney, with an 80% economic interest of the combined company expected to be owned at closing by Jeff Thramann. Under certain circumstances, these ownership percentages may be adjusted upward or downward based on the level of Auddia’s cash at closing.

 

The consideration to be paid to Thramann Holdings in the proposed transaction will consist of (i) shares of McCarthy Finney convertible preferred stock and (ii) $3.5 million aggregate principal amount of McCarthy Finney notes with a two year maturity date.

 

The closing of the merger will be conditioned on Auddia having at least $12 million cash on hand at closing in order to provide cash runway to fund McCarthy Finney to key future business milestones. There can be no assurances as to Auddia’s level of cash at closing.

 

 

 

 24 

 

The transaction has been unanimously approved by the board of directors of both companies. In connection with the approval of the merger agreement, Houlihan Capital provided a fairness opinion to Auddia’s special committee and board of directors.

 

The proposed transaction is expected to close in the first quarter of 2027, subject to customary closing conditions, including approvals by the Auddia stockholders, the effectiveness of the S-4 registration statement to be filed with the SEC to register the shares of McCarthy Finney stock to be issued in connection with the merger, and the continued listing of the combined company’s common stock on Nasdaq.

 

The proposed business combination is subject to a number of known and unknown risk and uncertainties. There can be no assurances that that such business combination will be approved by stockholders or will ultimately be consummated.

 

For more information about the business combination transaction, please see Auddia’s Current Report on Form 8-K filed with the SEC on February 17, 2026.

 

Mergers and Acquisitions Strategy

 

We are exploring various merger and acquisition options as part of a broader strategy which aims to scale the business more rapidly; accelerate user adoption and subscriber growth; enter new markets (international); and open new pathways toward raising capital. The overall strategy focuses on three areas: (1) acquiring retained customers of the Discovr Radio platform to generate significant subscription revenue, (2) acquiring retained users of faidr to supply the audience to Discovr Radio customers (3) scaling the faidr userbase and the Discovr Radio customer base once we’ve achieved product-market fit.

 

Nasdaq Deficiency Notices

  

During 2022, 2023 and 2024, the Company received notices from Nasdaq indicating that the Company was not in compliance with (i) Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing or (ii) Nasdaq Listing Rule 5550(a)(2) which requires companies listed on The Nasdaq Stock Market to maintain a minimum of a $1.00 bid price for continued listing.

 

On May 24, 2024, we received a letter from Nasdaq indicating that we had regained compliance with the equity requirement in Listing Rule 5550(b) (1). We will be subject to a Mandatory Panel Monitor for a period of one year from the date of the letter in accordance with application of Listing Rule 5815(d)(4)(B).

 

On October 16, 2024, we received a written notice from Nasdaq indicating that we were not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. The bid price notice does not result in the immediate delisting of our common stock from the Nasdaq Capital Market. The bid price notice indicated that we have 180 calendar days (or until April 14, 2025) in which to regain compliance. If at any time during this 180 calendar day period the bid price of our common stock closes at or above $1.00 per share for a minimum of ten consecutive business days, the Nasdaq staff will provide us with a written confirmation of compliance and the matter will be closed.

 

On April 14, 2025, Nasdaq notified us that we were in compliance with the $1.00 minimum bid price requirement.

 

Reverse Stock Splits

 

On March 28, 2025, the Company effectuated a 1-for-17 reverse stock split.

 

On March 31, 2026, the Company effectuated a 1-for-7.7 reverse stock split.

 

The reverse stock splits did not change the authorized number of shares of the Company’s common stock. No fractional shares were issued and any fractional shares resulting from the reverse stock splits were rounded up to the nearest whole share.

 

 

 

 25 

 

The reverse stock splits applied to the Company’s outstanding warrants, stock options and restricted stock units. The number of shares of common stock into which these outstanding securities are convertible or exercisable were adjusted proportionately as a result of the reverse stock splits. The exercise prices of any outstanding warrants or stock options were also proportionately adjusted in accordance with the terms of those securities and the Company’s equity incentive plans.

 

Impact of Inflation

 

We have recently experienced higher costs across our business as a result of inflation, including higher costs related to employee compensation and outside services. We expect inflation to continue to have a negative impact throughout 2026, and it is uncertain whether we will be able to offset the impact of inflationary pressures in the near term.

 

Components of our results of operations

 

Revenue

 

Revenue consists of subscription fees paid by subscribers of our Discovr Radio platform, recognized ratably over the applicable subscription period. We expect this revenue stream to fluctuate based on subscriber growth, retention, and pricing changes.

 

Operating expenses

 

Direct costs of services

 

Direct cost of services consists primarily of costs incurred related to our technology and development of our Apps, including hosting and other technology related expenses. We expect our direct costs of services to increase in the future as we continue to develop and enhance our technology related to the faidr and podcasting Apps.

 

Sales and marketing

 

Our sales and marketing expenses consist primarily of salaries, direct to consumer (users for faidr and Discovr Radio) promotional spend and consulting services, all of which are related to the sales and promotion performed during the period. We expect our sales and marketing expenses to fluctuate period by period as we release new upgrades and enhancements within our Apps and look to generate revenue through customer acquisition, retention, and subscriptions.

 

Research and development

 

Since our inception, we have focused significant resources on our research and development activities related to the software development of our technology. We account for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. We cease capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by our management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are impaired and expensed during the period of such determination. We expect to continue to incur research and development expenses and capitalization in the future as we continue to develop and enhance faidr and develop the Discovr Radio platform.

 

 

 

 26 

 

General and administrative

 

Our general and administrative expenses consist primarily of salaries and related costs, including payroll taxes, benefits, stock-based compensation, and professional fees related to auditing, tax, general legal services, and consulting services. We expect our general and administrative expenses to continue to increase in the future as we right-size our operating activities and prepare for commercialization of our products and support our operations as a public company, including increased expenses related to legal, accounting, insurance, regulatory and tax-related services associated with maintaining compliance with exchange listing and Securities and Exchange Commission requirements, directors and officers liability insurance premiums and investor relations activities. 

 

Transaction Costs

 

During the three and nine months ended September 30, 2026, we incurred audit, accounting and legal costs in connection with the proposed business combination.

 

Restructuring

Our restructuring costs consist primarily of employee severance and related benefits, contract termination fees, and other costs incurred in connection with actions taken to streamline operations and align our cost structure with current business priorities.

 

Other income and expense

 

The other income and expense category primarily consists of interest expense attributed to the debt and conversion features of the Notes payable to related party.

 

Results of operations

 

Comparison of the Three Months Ended September 30, 2026 and 2025

 

The following table summarizes our results of operations:

 

    Three Months Ended        
    September 30, 2026   September 30, 2025   Change $   Change %
Revenue   $ 14,684     $ –       14,684       0.0%  
                                 
Operating expenses:                                
Direct cost of services     104,199       55,252       48,947       88.6%  
Sales and marketing     469,225       143,762       325,463       226.4%  
Research and development     408,118       317,626       90,492       28.5%  
General and administrative     687,579       698,940       (11,361 )     -1.6%  
Transaction costs     271,934       472,072       (200,138 )     -42.4%  
Restructuring     –       334,360       (334,360 )     -100.0%  
Depreciation and amortization     259,953       357,946       (97,993 )     -27.4%  
Total operating expenses     2,201,008       2,379,958       (178,950 )     -7.5%  
Loss from operations     (2,186,324 )     (2,379,958 )     193,634       -8.1%  
                                 
Other expense:                                
Interest income (expense)     73,067       (1,193 )     74,260       -6224.6%  
Total other expense     73,067       (1,193 )     74,260       -6224.6%  
Loss before Income taxes     (2,113,257 )     (2,381,151 )     267,894       -11.3%  
Provision for Income taxes     –       –       –       0.0%  
Net loss   $ (2,113,257 )   $ (2,381,151 )     267,894       -11.3%  

 

 

 27 

 

Revenue

 

Total revenues for the three months ended September 30, 2026 and 2025 were $14,684 and $0. The increase was primarily related to a successful Discovr Radio platform pilot launch.

 

Direct cost of services

 

Direct cost of services increased by $48,947 or 89% to $104,199 for the three months ended September 30, 2026 compared to $55,252. The increase is attributable to higher hosting and contractor fees.

 

Sales and marketing

 

Sales and marketing expenses increased by $325,463 or 226% to $469,225 for the three months ended September 30, 2026 compared to $143,762 for the three months ended September 30, 2025. The increase in sales and marketing expenses was primarily attributed to increase in marketing and promotional activities and trade show expenses.

 

Research and development

 

Research and development expenses increased by $90,492 or 28% to $408,118 for the three months ended September 30, 2026 from $317,626 for the three months ended September 30, 2025 primarily due to launch of Discovr Radio Platform and launch of faidr 2.0.

 

General and administrative

 

General and administrative expenses remained relatively flat for the three months ended September 30, 2026 compared to the three months ended September 30, 2025.

 

Transaction costs

 

Transaction expenses decreased by $200,138 or 42% to $271,934 for the three months ended September 30, 2026 compared to $472,072 for the three months ended September 30, 2025. The decrease is due to lower audit and legal expenses related to proposed reverse merger.

 

Restructuring costs

 

Restructuring expenses decreased by $334,360 or 100% for the three months ended September 30, 2026 compared to $334,360 for the three months ended September 30, 2025. There were no IT restructuring expenses incurred for the three months ended September 30, 2026 compared to the three months ended September 30, 2025.

 

Depreciation and amortization

 

Depreciation and amortization expenses decreased by $97,993 or 27% to $259,953 for the three months ended September 30, 2026 compared to $357,946 for the three months ended September 30, 2025. The decrease is due to fully amortized capitalized cost and lower capitalized software costs.

 

Other income (expense), net

 

Total other income (expenses) increased by $74,260 or 6,224.6% to $73,067 for the three months ended September 30, 2026 compared to ($1,193) for the three months ended September 30, 2025 primarily due to increase in interest income on return on funds in money market account and accrued interest on related party notes.

 

 

 

 28 

 

Results of operations

 

Comparison of the Nine Months Ended September 30, 2026 and 2025

 

The following table summarizes our results of operations:

 

    Nine Months Ended        
    September 30, 2026   September 30, 2025   Change $   Change %
Revenue   $ 22,268     $ –       22,268       0.0%  
                                 
Operating expenses:                                
Direct cost of services     225,310       169,388       55,922       33.0%  
Sales and marketing     1,376,636       564,360       812,276       143.9%  
Research and development     1,099,053       950,744       148,309       15.6%  
General and administrative     2,885,910       2,059,273       826,637       40.1%  
Transaction costs     1,176,664       472,072       704,592       149.3%  
Restructuring     –       334,360       (334,360 )     -100.0%  
Depreciation and amortization     757,451       1,147,981       (390,530 )     -34.0%  
Total operating expenses     7,521,024       5,698,178       1,822,846       32.0%  
Loss from operations     (7,498,756 )     (5,698,178 )     (1,800,578 )     31.6%  
                                 
Other expense:                                
Interest income (expense)     128,680       (4,191 )     132,871       -3170.4%  
Total other expense     128,680       (4,191 )     132,871       -3170.4%  
Loss before Income taxes     (7,370,076 )     (5,702,369 )     (1,667,707 )     29.2%  
Provision for Income taxes     –       –       –       0.0%  
Net loss   $ (7,370,076 )   $ (5,702,369 )     (1,667,707 )     29.2%  

 

 

 29 

 

Revenue

 

Total revenues for the nine months ended September 30, 2026 and 2025 were $22,268 and $0. The increase was attributable to Discovr Radio platform subscriptions.

 

Direct cost of services

 

Direct cost of services increased by $55,922 or 33% to $225,310 for the nine months ended September 30, 2026 compared to $169,388. The increase is attributable to higher hosting and contractor fees.

 

Sales and marketing

 

Sales and marketing expenses increased by $812,276 or 144% to $1,376,636 for the nine months ended September 30, 2026 compared to $564,360 for the nine months ended September 30, 2025. The increase in sales and marketing expenses was primarily attributed to increase in marketing and promotional activities and trade show expenses.

 

Research and development

 

Research and development expenses increased by $148,309 or 16% to $1,099,053 for the nine months ended September 30, 2026 from $950,744 for the nine months ended September 30, 2025 primarily due to launch of Discovr Radio Platform and launch of faidr 2.0.

 

General and administrative

 

General and administrative expenses increased by $826,637 or 40% to $2,885,910 for the nine months ended September 30, 2026 compared to $2,059,273 for the nine months ended September 30, 2025. The increase was due to bonuses and corporate public market consulting.

 

Transaction costs

 

Transaction expenses increased by $704,592 or 149% to $1,176,664 for the nine months ended September 30, 2026 compared to $472,072 for the nine months ended September 30, 2025. The increase is due to audit and legal expenses related to proposed reverse merger.

 

Restructuring costs

 

Restructuring expenses decreased by $334,360 or 100% for the nine months ended September 30, 2026 compared to $334,360 for the nine months ended September 30, 2025. There were no IT restructuring expenses incurred for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025.

 

 

 

 30 

 

Depreciation and amortization

 

Depreciation and amortization expenses decreased by $390,530 or 34% to $757,451 for the nine months ended September 30, 2026 compared to $1,147,981 for the nine months ended September 30, 2025. The decrease is due to fully amortized capitalized cost and lower capitalized software costs.

 

Other income (expense), net

 

Total other income (expenses) increased by $132,871 or 3,170% to $128,680 for the nine months ended September 30, 2026 compared to ($4,191) for the nine months ended September 30, 2025 primarily due to increase in interest income on return on funds in money market account and accrued interest on related party notes.

 

Income taxes

 

Since our inception in 2012, until the corporate conversion in February 2021, we were organized as a Colorado limited liability company for federal and state income tax purposes and treated as a partnership for U.S. income tax purposes. As such, we were not viewed as a taxpaying entity in any jurisdiction and do not require a provision for income taxes. Each member of our company was responsible for the tax liability, if any, related to its proportionate share of our taxable income.

 

Effective on February 16, 2021, we became treated as a corporation for U.S. income tax purposes and thus became subject to U.S. federal, state and local income taxes and are be taxed at the prevailing corporate tax rates. Among other things, we may begin to generate net operating losses at the corporate level.  We will account for income taxes using an asset and liability approach, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the financial statements but have not been reflected in taxable income. A valuation allowance is established to reduce deferred tax assets to its estimated realizable value, which is zero based on our operating history.

 

The Company has significant federal and state net operating loss carryforwards (“NOLs”). The proposed merger with Thramann Holdings is expected to result in an ownership change under Internal Revenue Code Section 382. An ownership change would subject the Company’s NOLs to an annual limitation based on the fair market value of the Company immediately prior to the ownership change multiplied by the applicable long-term tax-exempt rate. As a result, a substantial portion of the Company’s NOLs may not be available to offset future taxable income.

 

Because the Company maintains a full valuation allowance against its deferred tax assets, any such limitation would not impact the Company’s financial statements. The Company will continue to evaluate the potential impact of Section 382 limitations in future periods.

 

 

 

 31 

 

Going Concern

 

Our existing cash was $6,024,316 at September 30, 2026. We secured approximately $12.9 million in additional funding in 2026 through the date of this report, which will only be sufficient to fund our current operating plans into the second quarter of 2027. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

As a result of the Company’s recurring losses from operations, and the need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company’s ability to continue as a going concern.

 

Liquidity and capital resources

 

Sources of liquidity

 

We have incurred operating losses since our inception and have an accumulated deficit as a result of ongoing efforts to develop and commercialize our faidr and podcasting Apps. As of September 30, 2026, we had cash and cash equivalents of $6,024,316. We have working capital of approximately $5,601,721 as of September 30, 2026. We anticipate that operating losses and net cash used in operating activities will increase over the next 12 months as we continue to develop and market our products. We secured $12.9 million of financing during the nine months ended September 30, 2026 which will only be sufficient to fund our current operating plans into the second quarter of 2027.  We have based these estimates, however, on assumptions that may prove to be wrong. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

Equity Line Common Stock Purchase Agreement

 

On November 25, 2024, we entered into a new equity line Common Stock Purchase Agreement and a related registration rights agreement with White Lion. Pursuant to the Common Stock Purchase Agreement, we have the right, but not the obligation to require White Lion to purchase, from time to time, up to $10,000,000 in aggregate gross purchase price of newly issued shares of our common stock, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement. On July 30, 2025, we amended the equity line Common Stock Purchase Agreement from $10,000,000 to $50,000,000 and extended the commitment to December 31, 2027.

 

During the year ended December 31, 2025, the Company issued 129,221 shares of Common stock under the Equity Line Common Stock Purchase Agreement for total proceeds of $3.7 million.

 

At-the-Market Sales Agreement

 

The Company has entered into an At-the-Market Issuance Sales Agreement (the “Sales Agreement”) with Ascendiant Capital Markets, LLC, as sales agent (the “Agent”). Under the Sales Agreement, the Company may sell shares of its common stock having an aggregate offering price of up to $10,000,000 from time to time, through an “at the market offering” (the “ATM Offering”). The aggregate market value of shares that the Company can sell under the Sales Agreement will be subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction.

 

 

 

 32 

 

During the three and nine months ended September 30, 2026, the Company sold 0 and 98,043 shares, respectively under the Sales Agreement for proceeds of $0.9 million and currently has $0.0 million of unsold availability under the ATM facility.

 

During the year ended December 31, 2025, the Company issued 130,879 shares for aggregate proceeds of approximately $2.8 million under the ATM facility.

 

$2.3 Million Convertible Series B Preferred Stock and Warrants Financing

 

On April 23, 2024, the Company entered into a securities purchase agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $2,314,000 of gross proceeds in connection with the closing of this financing.

 

At the closing, the Company issued 2,314 shares of Series B convertible preferred stock (“Series B Preferred Stock”) at a purchase price of $1,000 per share of Series B Preferred Stock. The Series B Preferred Stock is convertible into Common Stock at an initial conversion price (“Conversion Price”) of $242.32 per share of Common Stock. The Company also issued warrants (“Warrants”) exercisable for 9,552 shares of Common Stock with a five-year term and an initial exercise price of $242.32 per share, which has been subsequently adjusted to $2.36. The proceeds of this financing, together with other available cash resources, were used to repay outstanding debt and for general corporate purposes.

 

Holders of the Series B Preferred Stock will be entitled to dividends in the amount of 10% per annum, payable quarterly. The Company has the option to pay dividends on the Series B Preferred Stock in additional shares of Common Stock. The Company also has the option to cumulate or “capitalize” the dividends, in which case the accrued dividend amount shall be added to the stated value of each share of Series B Preferred Stock.

 

On February 19, 2025, 140 shares of Series B Preferred stock and capitalized dividends were converted to 4,326 shares of Common Stock.

 

In April 2025, 447 shares of Series B Preferred stock and capitalized dividends were converted to 11,069 shares of Common stock.

 

On June 26, 2025, 192 shares of Series B Preferred stock and capitalized dividends were converted to 4,484 shares of Common Stock.

 

On August 5, 2025, the Company entered into a series of exchange agreements (the “Exchange Agreements”) with certain accredited investors to exchange 569 outstanding shares of the Company’s Series B preferred stock (including accrued dividends thereon) for 17,237 shares of common stock at an exchange price of $20.41 per common share. The issuance of the exchange common shares is intended to be exempt from registration pursuant to the exemptions under Section 3(a)(9) of the Securities Act of 1933, as amended (the “Securities Act”).

 

As of September 30, 2026, no Series B Preferred Stock remains outstanding.

 

$750,000 Series C Preferred Stock and Warrants Financing

 

On June 30, 2025, the Company entered into a Securities Purchase Agreement with accredited investors for a convertible preferred stock and warrants financing. The Company received $750,000 of gross proceeds in connection with the closing of this financing.

 

At the closing, the Company issued 750 shares of Series C convertible preferred stock (“Series C Preferred Stock”) at a purchase price of $1,000 per share of Series C Preferred Stock. The Series C Preferred Stock is convertible into Common Stock at an initial conversion price (“Series C Conversion Price”) of $36.73 per share of Common Stock. The Company also issued warrants exercisable for 40,841 shares of Common Stock with a five year term and an initial exercise price of $36.73 per share, which has been subsequently adjusted to $2.36.

 

On April 23, 2026, the Company entered into an exchange agreement (the “Exchange Agreement”) with the accredited investors to exchange 750 outstanding shares of the Company’s Series C preferred stock plus capitalized dividends to date for 216,525 shares of common stock at an exchange price of $3.91 per common share. No shares of Series C preferred stock remain outstanding.

 

 

 

 33 

 

As of September 30, 2026, no Series C Preferred Stock remains outstanding.

 

The proceeds of this financing, together with other available cash resources, will be used for general corporate purposes.

 

April 2026 Registered Direct Offering  

 

On April 27, 2026, the Company closed a best-efforts registered direct offering (the “Offering”) of 1,405,006 shares of common stock, together with, in lieu of common stock for certain investors, 3,679,737 pre-funded warrants to purchase common stock (the “Pre-Funded Warrants”), and accompanying common stock purchase warrants to purchase up to 5,084,743 shares of common stock (the “Common Warrants”). The combined public offering price was $2.36 per share (or per Pre-Funded Warrant) and accompanying Common Warrant. Gross proceeds were $11,999,993 (approximately $12.0 million), before deduction of a 7.0% cash fee payable to the placement agent and other offering expenses, together totaling approximately $1.2 million. Gross proceeds were allocated among the common stock, pre-funded warrants and common warrants on a relative fair value basis.

 

The Pre-Funded Warrants have an exercise price of $0.001 per share, which was pre-funded at closing, and no stated expiration date; they remain exercisable until exercised in full. The Common Warrants have an exercise price of $2.36 per share and expire earlier of (i) five years from the initial exercise date and (ii) the consummation of the Company’s pending merger with Thramann Holdings, LLC (the "Merger"). All 3,679,737 Pre-Funded Warrants were exercised by April 30, 2026 for an aggregate exercise price of $3,680; As of September 30, 2026, 1,000 common warrants were exercised at $2.36 with the proceeds of $2,359.

 

All 3,679,737 Pre-Funded Warrants were exercised in full as of September 30, 2026. Upon exercise, the Company received aggregate cash proceeds of $3,680 and reclassified $5,711,457 from the Pre-Funded Warrants equity account to common stock and additional paid-in capital. No Pre-Funded Warrants remain outstanding. This exercise activity does not affect the fair value classification or measurement of the Common Warrant liability.

 

Cash Flow Analysis

 

Our cash flows from operating activities have historically been significantly impacted by our investment in sales and marketing to drive growth, and research and development expenses. Our ability to meet future liquidity needs will be driven by our operating performance and the extent of continued investment in our operations. Failure to generate sufficient revenues and related cash flows could have a material adverse effect on our ability to meet our liquidity needs and achieve our business objectives.

 

The following table summarizes the statements of cash flows for the nine months ended September 30, 2026 and 2025:

 

   For the Nine Months Ended
September 30,
 
   2026   2025 
Net cash provided by (used In):          
Operating activities  $(6,916,748)  $(4,335,812)
Investing activities   (1,961,953)   (534,012)
Financing activities   11,716,032    4,890,671 
Change In cash  $2,837,331   $20,847 

 

Operating activities

 

Cash used in operating activities for the nine months ended September 30, 2026 was $6,916,748, primarily resulting from our net loss of ($7,370,076), change in working capital of $373,657 primarily related to a decrease in accounts payable and accrued liabilities, lease liability and prepaid assets, and non-cash charges of $757,451 related to depreciation and amortization, $45,326 in share based compensation expense and $24,208 in amortization of ROU. Cash used in operating activities for both periods consisted of personnel-related expenditures, marketing and promotion costs, and public company administrative support costs such as legal and other professional support services.

 

 

 34 

 

Investing activities

 

Cash flows used in investing activities for the nine months ended September 30, 2026 was $1,961,953, consisting primarily of $1,175,269 in loans to related parties, $796,349 capitalization of software development expenses and $10,138 patent expenses.

 

Financing activities

 

Cash flows generated in financing activities for the nine months ended September 30, 2026 was $11,716,032 primarily related to cash proceeds from the issuance of offering of prefunded warrant, Common warrant and Common stock partially offset by repayments to notes payable of $60,520 and offering costs of $1,117,723.

 

Funding Requirements

 

We historically have incurred significant losses and negative cash flows from operations since our inception and had an accumulated deficit of $104,683,742 and $97,283,343 as of September 30, 2026 and December 31, 2025, respectively. As of September 30, 2026 and December 31, 2025, we had cash and cash equivalents of $6,024,316 and $3,186,985, respectively. Our cash is comprised primarily of demand deposit accounts and money market funds. We secured $12.9 million of financing during the nine months ended September 30, 2026 which will only be sufficient to fund our current operating plans into the second quarter of 2027.  We have based these estimates, however, on assumptions that may prove to be wrong. We will need additional funding to complete the development of our full product line and scale products with a demonstrated market fit. Management has plans to secure such additional funding. If we are unable to raise capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the development, and marketing and promotion of faidr. In addition, we expect to continue to incur additional costs associated with operating as a public company, including legal, accounting, investor relations and other expenses. Our future funding requirements will depend on many factors, including, but not limited to:

 

· the scope, progress, results, and costs related to the market acceptance of our products;
· the ability to attract podcasters and content creators to faidr and retain listeners on the platform;
· the costs, timing, and ability to continue to develop our technology;
· effectively addressing any competing technological and market developments; and
· avoiding and defending against intellectual property infringement, misappropriation and other claims.

 

 

 

 35 

 

Off-balance sheet arrangements

 

We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

 

Critical Accounting Estimates

 

Our financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. On an ongoing basis, we continually evaluate our estimates and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results may materially differ from these estimates made by management under different assumptions and conditions.

 

Certain accounting policies that require significant management estimates and are deemed critical to our results of operations or financial position, are described below. Accordingly, these are the policies we believe are the most critical to aid in fully understanding and evaluating our financial condition and results of operations.

 

Software Development Costs

 

The Company accounts for costs incurred in the development of computer software as software research and development costs until the preliminary project stage is completed, management has committed to funding the project, and completion and use of the software for its intended purpose is probable. The Company ceases capitalization of development costs once the software has been substantially completed and is available for its intended use. Software development costs are amortized over a useful life estimated by the Company’s management of three years. Costs associated with significant upgrades and enhancements that result in additional functionality are capitalized. Capitalized costs are subject to an ongoing assessment of recoverability based on anticipated future revenues and changes in software technologies. Unamortized capitalized software development costs determined to be in excess of anticipated future net revenues are impaired and expensed during the period of such determination.

 

Equity-based compensation

 

Certain of our employees and consultants have received grants of common shares in our company. These awards are accounted for in accordance with guidance prescribed for accounting for equity-based compensation. Based on this guidance and the terms of the awards, the awards are equity classified. The common shares receive distributions if any in an order of priority in accordance with our limited liability company agreement.

 

The fair value of each award is determined using the Black-Scholes option-pricing model which values options based on the stock price at the grant date, the expected life of the option, the estimated volatility of the stock, and the risk-free interest rate over the expected life of the option. The expected volatility was determined considering comparable companies historical stock prices as a peer group for the fiscal year the grant occurred and prior fiscal years for a period equal to the expected life of the option. The risk-free interest rate was the rate available with a term equal to the expected life of the option. The expected life of the option was estimated based on a mid-point method calculation.

 

 

 

 36 

 

Emerging growth company and smaller reporting company status

 

The Jumpstart Our Business Startups Act of 2012 permits an “emerging growth company” such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to not “opt out” of this provision and, as a result, we will adopt new or revised accounting standards at the time private companies adopt the new or revised accounting standard and will do so until such time that we either (i) irrevocably elect to “opt out” of such extended transition period or (ii) no longer qualify as an emerging growth company.

 

We are also a “smaller reporting company” meaning that the market value of our stock held by non-affiliates is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

There have been no changes in internal control over financial reporting during the nine months ended September 30, 2026.

 

 

 

 

 

 

 

 37 

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective. The Company’s disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (ii) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

 

Changes in Internal Control Over Financial Reporting

 

We did not repurchase any of our equity securities during the quarter ended September 30, 2026.

 

 

 

 

 

 

 

 

 

 

 

 38 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we are involved in various disputes, claims, suits, investigations, and legal proceedings arising in the ordinary course of business. We believe that the resolution of current pending legal matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows. Nonetheless, we cannot predict the outcome of these proceedings, as legal matters are subject to inherent uncertainties, and there exists the possibility that the ultimate resolution of these matters could have a material adverse effect on our business, financial condition, results of operations or cash flows. For additional information, see “Note 5. Commitments and Contingencies” to our financial statements included in this Form 10-Q.

 

Item 1A. Risk Factors

 

In addition to the information set forth in this Form 10-Q, you should carefully consider the risk factors disclosed under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to our risk factors from those included in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

There were no unregistered sales of equity securities of the Company during the period covered by this quarterly report which were not previously reported in a (i) Current Report on Form 8-K or (ii) Quarterly Report on Form 10-Q.

 

Issuer Purchases of Equity Securities

 

We did not repurchase any of our equity securities during the quarter ended September 30, 2026.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

During the quarter ended September 30, 2026, no director or officer of the Company adopted or terminated or otherwise had in effect a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 

 

 

 39 

 

Item 6. Exhibits

 

The exhibits required by Item 601 of Regulation S-K and Item 15(b) of this Quarterly Report are listed in the Exhibit Index below. The exhibits listed in the Exhibit Index are incorporated by reference herein.

 

Exhibit
Number
  Description of Document   Incorporated by reference from Form   Filing
Date
  Exhibit
Number
  Filed
Herewith
                   
1.1   At-The-Market Issuance Sales Agreement, dated August 22, 2025, by and between Auddia Inc. and Ascendiant Capital Markets, LLC.   8-K   08-22-2025   1.1    
2.1   Agreement and Plan of Merger, dated as of February 17, by and among New Holdco, Inc., Auddia Merger Sub, Inc., Thramann Merger Sub LC, Auddia Inc. and Thramann Holdings, LLC   8-K   02-17-2026   2.1    
2.2   Form of Plan of Conversion   8-K   02-22-2021   2.1    
3.1   Certificate of Incorporation of the Company   8-K   02-22-2021   3.1    
3.2   Certificate of Amendment to the Certificate of Incorporation of the Company dated February 23, 2024   8-K   02-27-2024   3.1    
3.3   Certificate of Amendment to the Certificate of Incorporation of the Company dated March 27, 2025   8-K   04/01/2025   3.1    
3.4   Certificate of Amendment to the Certificate of Incorporation of the Company dated March 30, 2026   8-K   4/02/2026   3.1    
3.5   Series B Convertible Preferred Stock Certificate of Designations dated April 23, 2024   8-K   04-29-2024   3.1    
3.6   Series C Convertible Preferred Stock Certificate of Designations dated June 30, 2025   8-K   06-30-2025   3.1    
3.7   Bylaws of the Company   8-K   02-22-2021   3.2    
3.8   Amendment to Bylaws dated September 6, 2024   8-K   09-12-2024   3.1    
3.9   Form of Warrant after Conversion from an LLC to a Corporation   S-1/A   01-28-2020   3.5    
3.10   Form of Merger Holding Company Special Preferred Stock Certificate of Designations   8-K   02-17-2026   3.1    
4.1   Form of Common Stock Certificate   S-1/A   10-08-2020   4.1    
4.2   Form of IPO Representative’s Common Stock Purchase Warrant   8-K   02-22-2021   4.1    
4.3   Description of Securities   10-K   03-31-2021   4.3    
4.4   Form of Merger Holding Company Senior Note   8-K   02-17-2026   4.1    
4.5   Form of April 2026 Pre-funded Warrant   8-K   04-27-2026   4.1    
4.6   Form of April 2026 Common Stock Warrant   8-K   04-27-2026   4.2    
10.1 # Form of Auddia Inc. 2020 Equity Incentive Plan   S-1/A   10-22-2020   10.3    
10.2 ** Agreement with Major United States Broadcast Company   S-1/A   01-28-2020   10.8    
10.3 # First Amendment to 2020 Equity Incentive Plan   S-8   08-10-2021   99.2    
10.4 # Second Amendment to 2020 Equity Incentive Plan   10-K   03-05-2025   10.5    
10.5 # Form of Stock Option Grant Notice and Stock Option Agreement under 2020 Equity Incentive Plan   S-8   08-10-2021   99.3    
10.6 # Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2020 Equity Incentive Plan   S-8   08-10-2021   99.4    
10.7 # Form of Inducement Stock Option Grant Notice and Inducement Stock Option Agreement   S-8   08-10-2021   99.5    
10.8 # Clip Interactive, LLC 2013 Equity Incentive Plan   S-8   08-10-2021   99.6    
10.9 # Form of Stock Option Grant Notice and Stock Option Agreement under 2013 Equity Incentive Plan   S-8   08-10-2021   99.7    
10.10 # Executive Officer Employment Agreement for Michael Lawless dated October 13, 2021   8-K   10-15-2021   10.1    
10.11 # Executive Officer Employment Agreement for Peter Shoebridge dated October 13, 2021   8-K   10-15-2021   10.2    

 

 

 

 40 

Exhibit
Number
  Description of Document   Incorporated by reference from Form   Filing
Date
  Exhibit
Number
  Filed
Herewith
10.12   Common Stock Warrant dated November 14, 2022   8-K   11-14-2022   10.2    
10.13   Common Stock Warrant for 600,000 shares dated April 17, 2023   8-K   04-21-2023   10.2    
10.14   Common Stock Warrant for 650,000 shares dated April 17, 2023   8-K   04-21-2023   10.3    
10.15 # Employment Agreement, effective as of November 27, 2023, between Auddia Inc. and John E. Mahoney   8-K   12-18-2023   10.1    
10.16   Form of Common Stock Warrant dated April 23, 2024   8-K   04-29-2024   10.2    
10.17   Form of Registration Rights Agreement dated April 23, 2024   8-K   04-29-2024   10.3    
10.18   Common Stock Purchase Agreement, dated as of November 25, 2024, by and between White Lion Capital, LLC and Auddia Inc.   8-K   11-25-2024   10.1    
10.19   Registration Rights Agreement, dated as of November 25, 2024, by and between White Lion Capital, LLC and Auddia Inc.   8-K   11-25-2024   10.2    
10.20   Form of Securities Purchase Agreement dated June 30, 2025   8-K   06-30-2025   10.1    
10.21   Form of Common Stock Warrant dated June 30, 2025   8-K   06-30-2025   10.2    
10.22   Form of Registration Rights Agreement dated June 30, 2025   8-K   06-30-2025   10.4    
10.23   Amendment 1, dated July 30, 2025, to Equity Line Common Stock Purchase Agreement, dated as of November 25, 2024, by and between White Lion Capital, LLC and Auddia Inc.   8-K   07-30-2025   10.1    
10.24   Form of Exchange Agreement dated August 5, 2025   10-Q   08-08-2025   10.35    
10.25 # Employment Agreement, effective as of July 1, 2025, between Auddia Inc. and Jeffrey Thramann   8-K   09-12-2025   10.2    
10.26   Form of Merger Support Agreement   8-K   02-17-2026   10.1    
10.27   Form of Merger Lock-Up Agreement   8-K   02-17-2026   10.2    
10.28   Form of Securities Purchase Agreement by and among the Registrant and Purchasers dated April 24, 2026   8-K   04-27-2026   10.1    
10.29   Form of April 2026 Exchange Agreement   8-K   04-29-2026   10.1    
10.30   Senior Unsecured Bridge Note of Thramann Holdings, LLC dated July 17, 2026   8-K   07-23-2026   10.1    
10.31   Senior Unsecured Bridge Note of LT350, LLC dated July 17, 2026   8-K   07-23-2026   10.2    
10.32   Senior Unsecured Bridge Note of Influence Healthcare, LLC dated July 17, 2026   8-K   07-23-2026   10.3    
10.33   Senior Unsecured Bridge Note of Voyex, LLC dated July 17, 2026   8-K   07-23-2026   10.4    
10.34   Amendment to Senior Unsecured Bridge Notes dated October 16, 2026   8-K   10-22-2026   10.1    
10.35   Form of Warrant Exchange Agreement, dated November 6, 2026, by and between the Company and various Warrant Holders   8-K   11-06-2026   10.1    
19.1   Insider Trading Policy   10-K   03-05-2025   19.1    
31.1   Section 302 Certification by the Corporation’s Chief Executive Officer               X
31.2   Section 302 Certification by the Corporation’s Chief Financial Officer               X
32.1   Section 906 Certification by the Corporation’s Chief Executive Officer               X
32.2   Section 906 Certification by the Corporation’s Chief Financial Officer               X
97.1   Auddia Clawback Policy   10-K   04-01-2024   97.1    

 

101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).

___________________________

# Indicates management contract or compensatory plan.
** Certain information contained in this Exhibit has been redacted and appears as “XXXXX” as the disclosure of same would be a disadvantage to the Registrant in the marketplace.

 

 

 

 41 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AUDDIA INC.
   
  By: /s/ Jeffrey Thramann
    Jeffrey Thramann
President, Chief Executive Officer, Director

 

  By: /s/ John Mahoney
    John Mahoney
Chief Financial Officer

 

 

Date: November 13, 2026

 

 

 

 

 

 

 42 

 

Keep reading